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A B S T R A C T
Most western countries are currently facing the reality of an age-
ing population that puts increasing pressure on social and health
systems that are struggling to maintain high quality of care. In
Europe it is estimated that the number of elderly people aged
above 65 will have doubled by 2060. Many of these people will
suffer from chronic conditions requiring permanent care. Of par-
ticular importance is the care of chronic patients, given the need
for continued care over long periods of time. In several chronic
pulmonary diseases, patients can suffer recurrent exacerbation
episodes. These episodes, with many different causes, lead to
severe breathing difficulties and can cause death.
In this thesis we focus on exploring the association of physical
activity to lung health parameters. We focused our work on cys-
tic fibrosis and chronic obstructive pulmonary disease patients
and a group of the general population recruited in the scope of
the KORA-Age study. The three main goals of the thesis were to
assess the feasibility of classifying exacerbation episodes in cys-
tic fibrosis and chronic obstructive pulmonary disease patients
and to propose and implement new parameters of physical ac-
tivity in the context of a cohort study such as KORA-Age.
We conducted four distinct studies with different subject groups
involving in total over 250 subjects. In all studies we asked the
subjects to wear a set of off-the-shelf accelerometers, including
GT1M, GT3X and RT3 sensors, to record physical activity pat-
terns for a total of up to 14 days during their daily life. The data
recorded by the sensors was then processed with Matlab and
several sets of features were extracted. Some of these features
were used as inputs in three different classification algorithms
in order to classify exacerbation episodes: logarithmic regression,
neural networks and support vector machines. Other features, in
the KORA-Age context, were tested and submitted to the central
study database for future use by the researchers cooperating in
the study.
We achieved an area under the curve of 67% with logarithmic
regression, 83% with neural networks and 90% with support vec-
tor machines when classifying exacerbation episodes in chronic
obstructive pulmonary disease. A neural network was able to
achieve an accuracy of 85% distinguishing cystic fibrosis patients
from healthy controls. We were not able to record enough data
to tackle the problem of classification of exacerbations in cystic
fibrosis. We proposed, discussed, extracted and tested a large set
of physical activity parameters for use in the KORA-Age study
v
by the collaborating researchers. The feedback from the subjects
in the early studies led us to identify several challenges in the ac-
ceptance of long-term monitoring with sensors, related to social
pressure and usability of the sensors.
The work on classification of normal days and days of exacer-
bations in COPD patients is, to our knowledge, the first attempt
to extract a set of features from accelerometer data. Overall SVM
showed to be the most robust classifier for this task. The best
results indicate an area under the curve of the classifier of 90%.
Nevertheless the number of patients and episodes is too low to
draw definitive conclusions. These results were achieved with
a significant number of features, but within a limited scope of
information extracted. We envisage that future approaches with
larger feature sets and with a larger scope of information present
in such features can improve the classification quality. Only then
is it feasible to aim at the clinical use of accelerometers in the
management of COPD patients.
Our approach achieved reasonable sensitivity and specificity
in distinguishing cystic fibrosis patients from control subjects
when conducting simple PA modeling with subsequent use of
a neural network. Naturally, the clinically interesting applica-
tion is not the distinction from healthy subjects but the indi-
vidual characterization of patients, as well as the possibility to
detect changes over time, possibly supported by an individually
trained neuronal network implemented in the activity monitor
itself. Correspondingly, the detection or prediction of exacerba-
tions in CF patients remains an issue for further studies.
We identified several barriers to participation and retention of
subjects in our studies: the social and comfort aspects of wear-
ing sensors for long periods, limitations of the sensors regarding
data reliability and battery limitations.
The next logical step in the effort to classify exacerbations in
COPD patients is to design a larger study, aiming to obtain data
for a statistically significant number of exacerbation episodes.
This is the essential step towards assessing the feasibility of the
proposed approach, and to gain better insight into the medical
consequences.
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We can only see a short distance ahead,
but we can see plenty there that needs to be done.
— Alan Turing
A C K N O W L E D G M E N T S
This thesis is the end result of a work in which I have relied on
the help, support and inspiration of many. First, I wish to thank
my supervisors Prof. Gunnar Hartvigsen and Prof. Alexander
Horsch for the fruitful discussions, ideas and motivational words
in every moment. They provided me the professional support
and encouragment that only world class researchers can achieve.
Second to the colleagues at Technical University of Munich
who where a significant part of this work was carried out. To
Lukas Gorzelniak that braved the path of a PhD in new grounds
at the same time as me. This lead us to a great team work with
shared goals and ideas, but also problems. Chen Chen joined
the team in Munich short after, bringing smiles and good mood
together with essential discussion on our studies. We shared an
office and each other’s laughs and the problems for two years.
Many of the researchers at Tromsø Telemedicine Laboratory
and the Medical Informatics and Telemedicine provided excel-
lent ground for idea sharing and introduced me to many crucial
concepts and ideas. I would like to thank Taxiarchis Botsis, Luis
Luque, Stein-Olav Skrovseth and Gustav Bellika for the discus-
sions along these years.
The research work in Munich was only possible with the ex-
change of ideas and cooperation with the teams at KORA-Age,
Klinik Bad Reichenhall and Ludwig Maximilians University. A
special word to Angela Döring for the continued support and
sharing of ideas.
I offer heartfelt thanks to my family for their care, support,
and encouragement. This thesis was also the result of me moving
abroad and thus bringing the pressure of the distance into the
family relations.
Finally a deep apreciation to Helena, able to walk along this
path never demanding or questioning the moments of absence.
vii
André Dias was supported by the Portuguese Foundation for
Science and Technology (FCT), under scholarship BD/39867/2007
and Research Council of Norway Grant No. 174934. Additional
research funding was provided by the Graduate School of Infor-
mation Science in Health (GSISH) and the Technische Univer-
sität München Graduate School.
viii
C O N T E N T S
i summary of studies 1
1 introduction 3
1.1 Challenges of an ageing population 3
1.2 Research problems and questions 5
1.3 Research Context 7
1.3.1 KORA cohort and KORA-Age study 8
1.3.2 Klinik Bad Reichenhall 9
1.3.3 Klinik Innenstadt of the Ludwig-Maximillians
University 9
1.4 Claimed contributions 10
1.5 Included papers 12
2 background 15
2.1 Accelerometers and Physical Activity 15
2.2 Importance and measurement of Physical Activity
16
2.3 Energy expenditure estimation 17
2.3.1 Gait parameters estimation 20
2.3.2 Circadian rhythm analysis 20
2.3.3 Seizure detection 21
2.3.4 Fall detection and prediction 22




3.1.1 GT1M and GT3X 27
3.1.2 RT3 29
3.1.3 GAITRite 29
3.1.4 Polar RS800 30
3.2 Subjects 30
3.2.1 Studies 30
3.2.2 Feasibility study 32
3.2.3 Chronic Obstructive Pulmonary Disease -
Klinik Bad Reichenhall 32
3.2.4 Cystic Fibrosis - Klinik Innenstadt 33
3.2.5 KORA cohort and KORA-Age study 34
3.3 Summary 35
4 methods 37
4.1 Sensor handling 37
4.2 Matlab 38
4.3 Cystic Fibrosis patients profiles 38
4.4 COPD exacerbation classification 39
4.5 Parameters of PA for lung research 43
ix
x contents
4.5.1 Code validation 46
4.6 Critique of the methods 50
4.7 Summary 50
5 results 51
5.1 CF Classification 51
5.2 Classification of days in COPD 52
5.3 Parameters of PA in KORA-Age 56
5.4 Acceptance and reliability 60
5.5 Summary 60
6 discussion 63
6.1 Classification of CF patients and controls 63
6.2 Classification of days in COPD 64
6.3 PA parameters for lung research 65
6.4 Recruitment and acceptance 65
7 conclusions 69
bibliography 73
ii included publications 91
iii additional publications 147
iv appendix 195
L I S T O F F I G U R E S
Figure 3.1 GT1M and GT3X. Both share the same cas-
ing design 28
Figure 3.2 Stayhealthy RT3, a tri-axial and wide use
sensor 29
Figure 3.3 Polar RS800CX heart rate sensor (not to scale) 30
Figure 3.4 Photo showing one of the COPD patients
wearing the arm and hip sensor 33
Figure 4.1 Plot showing the different pattern for ac-
celerometer data during transport 44
Figure 4.2 Artificial time series for test with constant
value 10 47
Figure 4.3 Test time series with normal random distri-
bution, average 100 and standard deviation
50 48
Figure 4.4 Artificial time series consisting of a sequence
1 to 100 repeated 48
Figure 4.5 Time series with pattern of 20 minutes value
0, 20 minutes value 100 49
Figure 4.6 Time series with pattern of 30 minutes value
0, 30 minutes value 100 49
Figure 5.1 Plot of the recorded data for the only CF
patient undergoing an exacerbation 52
Figure 5.2 Scatter plot showing different activity pro-
files for patients and control subjects 53
Figure 5.3 ROC curve for Feature Set 1 54
Figure 5.4 ROC curve for Feature Set 1 55
Figure 5.5 ROC curve for Feature Set 1 55
Figure 5.6 ROC curve for the feature set after selec-
tion 56
Figure 5.7 Example recording from the feasibility study
with missing data from heart rate sensor 62
L I S T O F TA B L E S
Table 1.1 Detailed contribution of the thesis: key find-
ings and research questions relation 11
Table 1.2 Papers included in the thesis and the re-
search partners involved 13
xi
Table 3.1 Main characteristics of readily available off-
the-shelf sensors for physical activity and
heart rate measurement (updated March 2010) 28
Table 3.2 Studies in this thesis, their goals, subjects
and criteria 31
Table 3.3 Relevant characteristics of the 7 subjects in
the feasibility study 32
Table 3.4 Characteristics of the participating COPD
patients 34
Table 3.5 Characteristics of the participating CF pa-
tients. Characteristics (FEV1 = forced expi-
ratory volume in one second, PaO2 = arte-
rial oxygen pressure, PaCO2 arterial pres-
sure for carbon dioxide, %pred = values as
percent of predicted normal values) 35
Table 3.6 Characteristics of the KORA-Age partici-
pating subjects. Values are average±standard
deviation 35
Table 4.1 Features extracted for the classification of
exacerbation episodes in COPD 42
Table 4.2 Features extracted from PA data for the KORA-
Age study 44
Table 5.1 Confusion matrix for PA modeling of Cys-
tic Fibrosis patients and controls using neu-
ral network and 8 features extracted from
accelerometry data 52
Table 5.2 Area under the curve for the several fea-
ture sets and classifiers for the classifica-
tion normal days and exacerbation in COPD 54
Table 5.7 Feedback from the patients about partici-
pation in the study 61
L I S T I N G S
xii
N O M E N C L AT U R E
AUC Area Under the Curve
CF Cystic Fibrosis
COPD Chronic Obstructive Pulmonary Disease
DLW Doubly Labeled Water
EE Energy Expenditure
FFT Fast Fourier Transformation
GSISH Graduate School of Information Systems in Health
IMSE Institute for Medical Statistics and Epidemiology
KORA Kooperative Gesundheitsforschung in der Region Augs-
burg
LMU Ludwig-Maximillians University of Munich
MEMS Micro-Electro-Mechanical Systems
MET Metabolic Equivalent of Task
NN Neural Network
PA Physical Activity
PAEE Physical Activity Energy Expenditure
SVM Support Vector Machines
TUM Technische Universitat Muenchen
VMU Vector Magnitude Unit
xiii

L I S T O F PA P E R S
No Title Publication
P1 Measuring Physical activity with
Sensors: A Qualitative Study (Dias,





P2 Assessing physical activity in the
daily life of cystic fibrosis patients






P3 Comparison of Recording
Positions of Physical Activity in
Patients with Severe COPD
Undergoing LTOT (Gorzelniak,




P4 Classification of exacerbation
episodes in Chronic Obstructive
Pulmonary Disease patients (Dias,
Gorzelniak, Schultz, Wittmann,





P5 Recommendations for Collecting
and Processing Accelerometry
Data in Older Healthy People






A D D I T I O N A L PA P E R S
No Title Publication
A1 Extracting Gait Parameters from






A2 Using a Robotic Arm to Assess the
Variability of Motion Sensors





A3 A Prototype of a Wireless Body
Sensor Network for Healthcare





A4 Does the Low Power Mode of the
Actigraph GT3X+ Accelerometer
influence the Device Output in




A5 Detecting Periodic Limb
Movements with Off-the-shelf
Accelerometers: A Feasibility
Study (Dias, Gorzelniak, Rudnik,
Stojanovic, Horsch)
Medinfo 2013
A6 Scale-Space Methods for Live
Processing of Sensor Data
(Skrøvseth, Dias, Gorzelniak,




A7 Multi-morbidity and successful
aging: the population- based








S U M M A RY O F S T U D I E S

1
I N T R O D U C T I O N
1.1 challenges of an ageing population
Most western countries are currently facing the reality of an
ageing population that puts increasing pressure on social and
health systems that are struggling to maintain high quality of
care. In Europe it is estimated that the number of elderly aged
above 65 will be double by 2060. Many of these people will suf-
fer from chronic conditions requiring permanent care. Future
changes in employment patterns with increasing percentages of
women working is expected to provoke a shortage of labor to
care for this population.
Of particular importance is the care of chronic patients [1],
given the need for continued care over long periods of time. To
maintain the current levels of care, we need to develop new ap-
proaches and concepts of care. New technologies and solutions
will result from extensive research and reach the mass market,
supporting the daily life of elderly people and chronic patients
[2]. Chronic diseases account for 75-85% of the total health care
spend in overall health care costs. One path to mitigate some
of the costs from chronic disease is to help the patients main-
tain stable health, stick to the medication regime, and quickly
respond to changes in vital signs before they turn into a costly
emergency. Through better monitoring, we can also provide a
higher quality of life for the patient and their loved ones.
As the world population grows older, the number of individu-
als needing some sort of assisted living is continuing to increase.
One of the possible approaches to reduce the burden and im-
prove the overall quality of life is to provide elderly people with
means to help them age gracefully in the comfort of their own
home. By providing non-obtrusive monitoring and simple daily
support from remote family, an elderly person may live in their
home for a longer period of time thereby avoiding costs of as-
sisted living.
In several chronic pulmonary diseases, patients can suffer re-
current exacerbation episodes. These episodes, with many dif-
ferent causes, lead to severe breathing difficulties and can cause
death. The recurrence of such episodes in turn can lead the
patients to enter a vicious circle of health status degradation.
Given the complicatons of exacerbation, patients become afraid
of such episodes and they tend to avoid exercise and activities
that may start them, but by doing so they lower the physical
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activity which contribute to worsening of the underlying pul-
monary disease.
The first proposals to assess human body movement using
electronic devices capable of measuring acceleration, later known
as accelerometers, happened in the 1950s. Obviously the devices
proposed at that time were expensive, bulky and not reliable,
making them unsuitable for applications outside a laboratory,
namely in daily living [3, 4, 5]. But, as with most electronic sys-
tems, the past decades provided a significant increase of qual-
ity of such devices, with significant motivation from the air-bag
industry. The recent generations of accelerometers provide low-
cost off the shelf devices, with high-volume production, in minia-
ture forms and reliable operation. The power consumption has
also been dramatically reduced to the point of autonomy of mea-
surement for several days on standard batteries.
Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality and represents a sub-
stantial economic and social burden throughout the world [6]
and it is the fifth leading cause of death worldwide and further
increases in its prevalence and mortality are expected in the com-
ing decades. The substantial morbidity associated with COPD is
often underestimated by health-care providers and patients; like-
wise, COPD is frequently under-diagnosed and under-treated.
COPD develops earlier in life than is usually believed. Tobacco
smoking is by far the major risk for COPD and the prevalence of
the disease in different countries is related to rates of smoking
and time of introduction of cigarette smoking[7]. Contribution
of occupational risk factors is quite small, but may vary depend-
ing on a country’s level of economic development. Severe defi-
ciency of alpha-1-antitrypsin is rare and the impact of other ge-
netic factors on the prevalence of COPD has not been established
[7]. COPD should be considered in any patient presenting with
cough, sputum production, or dyspnoea, especially if an expo-
sure to risk factors for the disease has been present. Clinical diag-
nosis needs to be confirmed by standardized spirometric tests in
the presence of not-fully-reversible airflow limitation. COPD is
generally a progressive disease and continued exposure to nox-
ious agents promotes a more rapid decline in lung function and
increases the risk of repeated exacerbations. Smoking cessation
is the only intervention shown to slow the decline, even if the
disease may still progress due to the decline in lung function
that normally occurs with aging, and some persistence of the
inflammatory response.
Cystic fibrosis (CF) is a hereditary disease that affects the
whole body causing progressive dysfunction of several organs
that ultimately leads to premature death. Approximately 1 in 25
individuals of European descent carry the CF allele as heterozy-
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gotes. In accordance with the allele frequency, disease incidence
is about 1:2500 births [8]. There are many genetic variants of the
CF disorder and significant effects of the genetic environment
that are associated with differences in severity and phenotype
of the disease. In CF patients, dysfunction of the CF Transmem-
brane Regulator protein creates disturbances in chloride trans-
port through the epithelium, resulting in dehydration of the mu-
cosal surfaces. The subsequent formation of dense mucus favors
the development and persistence of bacterial infections. This in
particular leads to a deterioration of pulmonary function. Pul-
monary causes are responsible for more than two thirds of all
CF-related deaths [8]. CF is diagnosed in males and females with
the same frequency but for reasons that remain unclear males
tend to have a longer life expectancy [9]. According to the CF
Foundation the average life expectancy for infants born with CF,
in the United States, in 2008 is 37.4 years[10].
Physical activity ( PA) and associated fitness levels seem to be
particularly important in CF, [11, 12] as patients with higher aer-
obic capacity have higher life expectancy [13], aerobic capacity
correlates with quality-of-life [14], and in adults with CF profes-
sional achievements are related to physical fitness [15].
Given the clinical impact of CF [16, 17], objective measurement
of PA appears to be an under explored research topic [18]. This
is especially in view of the possibility that PA could play a role
in the prediction of exacerbations in CF, similar to COPD [19, 20].
This would require patients to wear sensors for extended periods
of time or even all time. Although the extension of monitoring
is currently restricted by factors such as battery and memory
capacities of the devices, this could be technically handled in
future.
1.2 research problems and questions
Aiming at exploring the potential use of accelerometers as source
of information for robust models of lung diseases we set to ex-
plore the following general question:
How can we model pulmonary health parameters from short
and long term data recorded, in daily life settings, with accelerom-
eters?
Previous research looking into the associations between physi-
cal activity and lung health have focused on quantifying exercise
into parameters that were mostly based on questionnaires, such
as total time of exercise. The use of sensors became, in this scope,
a tool for more accurate data and while being easier to apply.
Unfortunately this approach leads to under-usage of the data
produced by accelerometers which is rich in details of the activi-
ties performed. Nevertheless, this first application provided the
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essential ground for testing and validation of such tools and that
resulted in the technological development and acceptance by the
medical community.
With better sensors, that are more reliable and have higher
sampling rates, comes the opportunity to explore more dimen-
sions of the recorded data. It raises the possibility to correlate
this rich information with the medical and health outcomes as-
sociated with lung diseases.
This thesis will focus on three different groups of subjects, cov-
ering a wide spectrum of baseline characteristics. I explored a
young group of patients, suffering from CF, that can be more
prone to accept new technologies and support our study. I worked
with COPD patients, with a higher average age and potentially
less aptitude to technology and acceptance of new methods of
care. I explored the utility of objective measurement of physical
activity with sensors in the general elderly population, in the
scope of epidemiology research.
Narrowing my general question to the groups of subjects in-
cluded in structured studies I defined a set of four health focused
questions:
• RQ1 - Is it feasible to study episodes of exacerbation in CF
patients by analysing accelerometer data?
• RQ2 - Can we distinguish normal days from exacerbation
in COPD patients looking at accelerometer data?
• RQ3 - Can we extract innovative parameters from accelerom-
eter data that are useful for pulmonary research in the pop-
ulation?
• RQ4 - What are the essential barriers to long term moni-
toring of PAand Heart Rate of chronic patients and elderly
people?
To achieve clear answers to these questions with medical focus it
is essential to apply existing computational methods to process
the accelerometer data and build classification tools. This need
raises a technology focused question:
• RQ5 - What is the performance of different methods ap-
plied to the previous research questions?
The first research question RQ1 focuses on a young group of pa-
tients suffering from chronic lung disease that has very impor-
tant impacts on their quality of life, to which physical activity
can be a crucial aspect of management of the disease, namely in
the event of exacerbation episodes. A very similar role of phys-
ical activity is also present in the management of COPD, the
focus of the second research question, RQ2, but in this case an
older group of patients.
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Besides these two patient groups, I also set out to explore
the measurement of physical activity in the elderly population
within the scope of lung health research, the focus of RQ4. The
role of PA is understood in the general quality of life, although
not well understood in the context of lung health.
The research question RQ4, has a bigger scope and was ad-
dressed in most of the studies we conducted, aiming at pro-
viding general knowledge to all researchers using similar tech-
niques in the future. It is an under reported question in most
studies that focus on the technical aspects of the sensors and the
medical findings, but might be a bottleneck in the wide adoption
of sensors in daily living.
I focused the research on data acquired by accelerometers,
mostly as a result of the reliability of these devices to accu-
rately measure physical activity in different settings and bet-
ter usability in medical scenarios. Technological development
of both hardware and software and decreasing prices and com-
plexity brought accelerometers into an increasing range of ap-
plications in health care. Current trends indicate that their use
will see a steady growth in the future, with new promising ap-
plications contributing to a better care of many conditions and
improving the daily life of people in need.
1.3 research context
This thesis culminates the research cooperation between several
clinical and research institutions both in Norway and Germany.
The thesis was developed in the scope of the Tromsø Telemedicine
Laboratory research program on medical sensor technology. The
project evolved into a close cooperation with the Institute of
Medical Statistics and Epidemiology (IMSE) of the Technische
Universitat München (TUM), where the field work took place,
including close work with medical clinics on discussion of re-
search goals and recruitment of subjects.
Stemming from the association to IMSE and the scope of a
PhD project I was invited as associated member of the Graduate
School of Information Systems in Medicine (GSISH ) at TUM.
This provided a dynamic and rich ground for discussion and in-
teraction with other researchers with very close interests. GSISH
also provided significant financial and logistical support for the
research work in Munich.
Since before the start of the project leading to this thesis IMSE
had established cooperation with the KORA collaboration, namely
on the KORA-Age project, on objective measurement of phys-
ical activity by means of accelerometers. Naturally this turned
to be an excellent working cooperation, providing us with high
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quality infrastructure of the research network and stimulating
innovative approaches to the questions at hand.
Given the large scope of the KORA-Age project and the neces-
sary preparatory work among all the partners, when combining
the timeframe of our research project with the overall KORA-
Age planning, we realized the opportunity for smaller scale stud-
ies, aiming to gather valuable knowledge for the larger KORA-
Age cooperation and topics of this thesis.
This research was funded/supported by the Graduate School
of Information Science in Health (GSISH) and the Technische
Universität München Graduate School. André Dias is supported
by the Portuguese Foundation for Science and Technology (FCT),
by scholarship SFRH/BD/39867/2007 and Research Council of
Norway Grant No. 174934.
1.3.1 KORA cohort and KORA-Age study
In the scope of this thesis we cooperated with the KORA-Age
project contributing to the technology and methods aspects of
PA assessment with sensors. KORA-Age is the current effort
within the large cohort initiative KORA.
KORA stands for Cooperative Health Research in the Augs-
burg Region (”Kooperative Gesundheitsforschung in der Region
Augsburg”) [21]. It constitutes a research platform that is used
by various national and international partners. The Infrastruc-
ture, organization and the administration of the KORA studies
are supervised by scientists at the Helmholtz Zentrum München,
more precisely by the Institute of Epidemiology and the Institute
of Health Economics and Health Care Management. Tight collab-
oration with the Central Hospital Augsburg, the local general
practitioners, the city of Augsburg and the local health office of
the university is needed to run the KORA surveys. Several part-
ners in Germany and abroad cooperate in the implementation
and evaluation of the surveys.
KORA-Age focuses on the research of determinants and conse-
quences of multi-morbidity and to look for means for successful
aging. The KORA-Age Consortium is part of the research pro-
gram „Health in Old Age“ financed by the German Ministry of
Education and Research.
The research consortium composed of clinicians, epidemiol-
ogists and social scientists has the objective to identify deter-
minants and consequences of multi-morbidity in aged persons,
based on the KORA cohort. The KORA-Age network is orga-
nized into several sub-projects, each with specific aims, but shar-
ing common infrastructure and data.
We conducted cooperation within the scope of lung sub-project
and aging sub-project 1 of KORA-Age. The former focuses on
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surveys of lung function in the general elder population, and the
later explores the factors and conditions associated with frailty
in elderly population. For both sub-projects the recruitment pro-
cess was responsibility of the KORA study center and the coop-
eration hospital.
Three studies compose KORA-Age: Mortality follow-up of sub-
jects of the KORA cohort age 65 to 94 years in 2008 and mor-
bidity follow-up by means of a telephone interview of all liv-
ing subjects[21]. Examinations in a random sample of the cohort,
age 65 to 89 years assessing intermediate phenotypes of diseases
and aging, functioning and disability, mental health and cogni-
tive impairment, social support and attachment. An intervention
study with myocardial infarction survivors aged 75 years and
older. The details of the KORA-Age study can be found else-
where [22].
1.3.2 Klinik Bad Reichenhall
The Clinic Bad Reichenhall is a traditional, nationally recognized,
specialized clinic for patients with respiratory diseases and mus-
culoskeletal problems. Bad Reichenhall is a privileged location
with its mild climate and excellent air quality of a wide and flat
valley surrounded by mountains. The clinic has permanent reser-
ach activity setting standards for many treatments[23]. For this
it cooperates with several research institutions across Germany.
We established a long term cooperation effort with this clinic,
starting with a study on physical activity patterns of severe COPD
patients. While working at the clinic we had opportunity to dis-
cuss and deepen our knowledge of COPD and impacts on pa-
tients life, through direct contact with care givers and the pa-
tients.
1.3.3 Klinik Innenstadt of the Ludwig-Maximillians University
In order to focus on a group of patients in younger age groups
we established a working cooperation with the Medizinische
Klinik Innenstadt of the Ludwig-Maximillians Universität (LMU).
We cooperated with Privatdozent Dr. Rainald Fischer at the Pul-
monary section. The clinic provides care to most patients with
diagnosed Cystic Fibrosis in the city, more than one hundred in
total. This provided a valuable recruitment pool for this rare dis-
ease. We agreed with the medical staff to conduct a short study
with two-fold34bjectives: assess the usability of the PA sensors in
long term monitoring and assess the feasibility of predicting ex-




The goal of this thesis is to investigate the potential of accelerom-
eter devices in the care and research of chronic lung diseases.
Based on this objective and the answers provided to the research
questions, I claim that the thesis has scientific contributions. The
main contributions are:
• Knowledge of the physical activity patterns of Cystic Fibrosis pa-
tients when compared to healthy subjects. Papers appendidy
sample, the physical activity patterns of CF patients differ
from the patterns of healthy subjects. This gives us an in-
dication that larger and better designed studies might be
able to identify associations between physical activity and
health status of CF patients.
• Implementation of a classification system to distinguish normal
days from exacerbation episodes in patients suffering from COPD.
I implemented and tested several features extracted from
accelerometer data and used them for the classification of
normal days and exacerbation days in patients suffering
from COPD. This is a first and very simple attempt at the
long term goal of predicting exacerbations in these patients
and, if possible, contribute to the prevention of exacerba-
tions by preventive care.
• Exploration of the associations of Cystic Fibrosis and COPD
health parameters to physical activity estimated by accelerometer
data. I extracted several innovative features from accelerom-
eter data that can be used for classification tasks and poten-
tially for exploration of other health related questions that
can be influenced by patterns of physical activity.
• Methodological contributions to the long term monitoring and
analysis of physical activity data recorded with accelerometers.
In the scope of the KORA-Age study and generally appli-
cable to all studies I developed several methodological and
usability recommendations for successful long term moni-
toring of physical activity with accelerometers.
• Exploration of usability and acceptance problems arising from
long term monitoring. The research identified usability con-
cerns from a group of young patients towards the long
term use of sensors, namely fashion and social pressure. I
decided to drop the use of heart rate sensors in this thesis
over the concerns of usability and reliability earlier in the
process.
Moreover, five papers have been produced and included in this
thesis. Table 1.1presents a synthesis of key findings and they
presence in each of the papers.
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Accelerometer data may provide
sufficient information to
distinguish exacerbation episodes
from normal days in COPD
P3, P4 RQ2,
RQ3
Accelerometer data can be the
source of important PA
parameters for cohort studies
P5 RQ3
Our best classification results
were achieved with Support





Heart rate monitoring poses
challenges in long term
monitoring studies
P1 RQ1






This thesis includes five papers, as presented in table 1.2.
The relevance of each paper to the thesis and my contribution
to each papers are presented below:
• P1: Measuring Physical activity with Sensors: A Qualita-
tive Study (Dias, Fisterer, Lamla, Kuhn, Hartvigsen, Horsch
2009).
Relevance to this thesis: The goal of this work was to gain
experience on the acceptance and technical questions raised
by long term monitoring with sensors. We recruited healthy
volunteers and monitored the usage of a set of sensors,
collecting information about the data quality and the con-
cerns shown by the users.
My contribution: Bernhard Fisterer was responsible for the
recruitment and supervision of the study. I discussed the
study, analyzed the data and wrote the draft paper.
• P2: Assessing physical activity in the daily life of cystic fi-
brosis patients (Dias, Gorzelniak, Jorres, Fischer, Hartvigsen,
Horsch 2012).
Relevance to this thesis: This study focused on a young
population of chronically ill subjects. We established a co-
operation with the Pneumonologie section of the Univer-
sity hospital of the Ludwig Maximilians University in Mu-
nich for the study. We recruited several Cystic Fibrosis pa-
tients in order to study the feasibility of using physical ac-
tivity to classify exacerbation events. At the same time we
recorded their concerns about the usability of the sensors.
My contribution: I started, together with Alexander Horsch
and Rudolf Jörres, the collaboration with the university
hospital, discussing the study setup with Rainald Fischer.
Later Lukas Gorzelniak and I conducted the recruitment
of patients. I analyzed the data from the study and wrote
the text.
• P3: Comparison of Recording Positions of Physical Activity
in Patients with Severe COPD Undergoing LTOT (Gorzel-
niak, Dias, Schultz, Wittman, Karrasch, Jorres, Horsch 2012)
Relevance to this thesis: In this study we explored the sta-
tistical association of PA to the COPD health outcomes. It
provides us insights, as well, to the best body locations for
measuring PA and knowledge on PA that was used on the
setup of further studies.
My contribution: I contributed to the study design with all
the authors. Later Lukas Gorzelniak and me recruited the
patients at Klink Bad Reichenhall, with local support from
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Konrad Schultz. I contributed the analysis of the data, with
Lukas Gorzelniak, and the writing of the final text.
• P4: Classification of exacerbation episodes in Chronic Ob-
structive Pulmonary Disease patients (Dias, Gorzelniak, Schultz,
Wittman, Rudnik, Jorres, Horsch 2012)
Relevance to this thesis: In this study we explored the data
set of PA in COPD in order to classify exacerbation episodes.
We implemented several features and machine learning
methods that provided insight to the capacity of classify-
ing normal days and exacerbation days in COPD patients.
The results indicate good potential for the approach, with
reasonable classification accuracy, but still not medically
relevant results.
My contribution: This work was based on the same ac-
celerometer data as paper P3. I discussed the study design
with all the authors, and implemented and tested all the
necessary code for the classification system. I analyzed the
data and wrote the final text.
• P5: Recommendations for Collecting and Processing Ac-
celerometry Data in Older Healthy People (Ortlieb, Gorzel-
niak, Dias, Schulz, Horsch 2012)
Relevance to this thesis: This paper provides a summary of
our experience in the measurement and processing of the
accelerometer data recorded in the scope of the KORA-Age
project. This constitutes a methodological contribution for
large cohort studies.
My contribution: In this study I participated in the discus-
sion and planing of the PA measurement activities. I de-
veloped the subject deliverable information sheets and im-
proved the handling protocol for the sensors. I developed
the scripts for processing the recorded data and planed
and executed the testing procedures for the code. I also
work to the final text of the paper.
2
B A C K G R O U N D
This chapter presents the importance of objective measurement
of several health related parameters with the use of accelerome-
ters, and introduces the essential concepts and technologies used
in the development of accelerometer sensors. We give greater
attention to the measurement of physical activity and energy
expenditure, given that they are the main research topic of the
community.
2.1 accelerometers and physical activity
Sensors allow the detection, analysis, and recording of physical
phenomena that are hard to quantify directly by converting the
underlying phenomenon into a convenient signal. Sensors con-
vert physical measurements such as velocity, displacement, force,
acceleration, pressure or flow into electrical signals. The value of
the original physical parameter can then be calculated taking
into account the appropriate characteristics of the electrical sig-
nal (amplitude, frequency, pulse-width, etc.).
An accelerometer is a transduction device, a sensor, that con-
verts mechanical energy into an electrical signal. They are es-
sentially force sensors that are capable of measuring linear ac-
celeration along one or several directions [24, 25]. They are dis-
tinct from gyroscopes, another inertial sensor that measures an-
gular acceleration. The basic building concept of accelerometers
is of having a seismic mass attached to a mechanical suspension
that has a reference to a fixed frame. Inertial forces, according to
Newton’s second Law, will move the seismic mass. This move-
ment can be measured and converted to an electrical current or
voltage.
Commercially available motion sensing devices are based on
3 distinct technologies: piezoelectric, piezoresistive, differential
capacitor, all implementing the basic concept of a mass system.
Piezoelectric accelerometers are made of a piezoelectric ele-
ment that is bent by a seismic mass when the device undergoes
acceleration. This bend causes a charge to accumulate in one side
of the element, producing an output voltage proportional to the
applied acceleration. These sensors have high outputs for small
strains and the potential of a large dynamic range [26]. Piezoelec-




Piezoresistive accelerometers are typically manufactured from
a surface micro machined polysilicon structure, where springs
arranged in Wheatstone configuration sit. When forces are ap-
plied the electrical resistance of the surface changes, produc-
ing an output voltage change proportional to the acceleration.
These sensors, given their characteristics, are useful for detecting
low frequency vibrations. The major drawbacks of piezoresistive
sensing are the temperature-sensitive drift and the lower level of
the output signals [26].
Differentiable capacitor accelerometers exploit the effect of pro-
portional capacitance change due to applied acceleration. They
are built around a differentiable capacitor with central plates
attached to moving mass and fixed external plates. Accelera-
tion changes the balance of the capacitor and produces an out-
put voltage. The capacitive nature of the sensor provides a low
power consumption, large output level, fast response and low
noise levels. Currently this kind of accelerometer has widely
been used in most applications [26].
2.2 importance and measurement of physical activ-
ity
Human movement is the result of many contributing factors
such as physiology, mechanics, psychology, etc. Analyzing, as-
sessing and quantifying human movement is an important source
of knowledge for care givers and clinicians to diagnose and
treat a variety of conditions. Many conditions have been directly
linked to the quantity and quality of human movement, for in-
stance, obesity, osteoarthritis, stroke and COPD [20]. In COPD
for instance, according to the global initiative on lung diseases,
the dyspnea or shortness of breath prevent regular PA which
leads to a decommissioning of the overall condition. For this
condition the usual recovery program consists of programmed
moments of low intensity exercise, such as walking, to improve
lung function and overall quality of life [20].
Furthermore, there may be beneficial effects for many other
diseases and causes of death which have so far been less stud-
ied. The physical activity and patterns of movement have been
focused in the scope of other conditions, not directly related, in
literature, to PA. For instance, Pan et al. [27] analyzed PA and so-
cial engagement in children with autism, concluding that such
children that have frequent interactions displayed a higher level
of PA.
It is assumed that PA is one of the factors, together with to-
bacco control and body weight control, yielding the most promis-
ing approach to alleviate the burden of disease in industrial-
ized countries [28]. Nevertheless, PA is a complex phenomenon
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which is only partly understood, especially the interrelation of
its components and how they contribute to the development of
chronic conditions. PA is a multidimensional construction that
can be regarded as type of activity, frequency, duration, intensity,
and setting. It can be defined as body movements produced by
the activation of skeletal muscle leading to an increase of energy
expenditure above the basal level [28]. These body movements
induce a machinery of metabolic effects on the cellular, organ,
and whole body level which are responsible for the expected
impact on disease.
Such findings indicate the importance of PA as a factor for
general life quality and well being.
Several methods exist for the assessment of movement, includ-
ing questionnaires or diaries, direct observation and technolog-
ical (force plates, video recording and optical motion analysis).
Many of these techniques have clear drawbacks for long term
measurement, or pose a significant burden for the subjects.
The real importance of PA on health and quality of life is
likely to be underestimated due to substantial measurement er-
ror in the existing PA assessments. Most epidemiological studies
to date exclusively used questionnaires to assess PA, with most
of them focusing on estimates of energy expenditure. However,
there is wide agreement that PA questionnaires have limited va-
lidity to estimate energy expenditure and to quantify PA. Mis-
classification of PA would tend to bias studies towards finding
no association. Therefore, it could be suspected that more precise
measures would likely yield even stronger evidence for known
associations or reveal still unknown associations with health out-
comes [29][5].
2.3 energy expenditure estimation
Energy expenditure (EE) can be estimated from measurements
of physical activity. The most reliable methods in use, considered
as gold standards for EE, are the doubly labeled water method
(DLW) and indirect calometry, that consists of measuring oxygen
consumption, carbon dioxide production and parameters from
cardiac and pulmonary function. Nevertheless these are complex
and expensive methods, posing a financial and skills barrier in
large scale studies[30]. Despite the availability of such complex
methods and techniques that assist in the determination of the
energy expended by the human body, an accelerometer provides
a simple tool that gives details of such measurements in order
to make the relevant medical intervention on a patient. In the
free living environment, the accelerometer can be used to deter-
mine the amount of energy used for activities such as running
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and walking. Such specific activities are identifiable their pattern
movement when recorded at the anterior to posterior positions.
The acceleration values recorded during activities can be used
as an input to several different models and equations that es-
timate the energy expenditure of the recorded activity[31]. De-
pending on several factors such as age, weight, height, gender,
etc, these models estimate the Physical Activity Energy Expendi-
ture (PAEE) that can be combined with Rest Energy expenditure,
to achieve the Total Energy Expenditure. During the last years,
intense research has been devoted to build and validate these
models. Nevertheless, they don’t achieve high accuracy rates
when compared to gold standard methods such as DLW. Vali-
dation of such models is hard, not only because of the factors
influencing accuracy, but also the dependence on the particular
hardware used and the wide range of accelerometers available.
There are a number of other systems that are used in the deter-
mination of physical energy consumed for use in, for instance,
in the evaluation of the progress of patient’s recovery therapy.
Magnitude of acceleration picked by various accelerometer tar-
get parameters is converted to represent the level of activity in
the respective parameter, for instance walking [32].
Other environmental factors such as external vibrations and
possible gravity related artifacts that can cause some extra accel-
eration detection can result in the wrong data interpretations[33].
An analysis of such data is therefore supposed to include the ac-
tual factors that are likely to affect the ideal real figure expected
in the measurement of energy expended by the patient. Certain
positions on the body are more representative of bodily motion
than others for instance the amount of acceleration recorded at
the lower back is not the same as that on the lumbar cavity and
vertebrae regions. Specificity is important in analyzing the actual
acceleration for the translations thereon to imply respective en-
ergy expenditure. Special analysis enhancement techniques such
as pressure detection on the accelerometer were used to reveal
the various changes in the vertical and horizontal motion posi-
tions.
The lack of satisfactory results on estimation of PAEE is due
to the models not fitting to all modes of activity, wich varies in
intensity, type or duration for instance. The equations were de-
veloped for certain movement patterns, and so can’t cope with
movements not picked up by the sensors or totally different
patterns of movement. To overcome these limitations some re-
searchers have proposed two different sensors (accelerometer
and heart rate) [34, 35, 36], using branched equations or cross-
sectional time series [31]as modeling technique. Nevertheless,
usability poses a significant barrier for this approach.
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Besides simple formulas for estimating PAEE, some authors
have explored more robust modeling techniques such as neural
networks [37][38], reporting a significant reduction of the confi-
dence interval associated with the estimations.
For estimating EE in children[39], several equations have been
proposed, such as Freedson et al. [40], Hendelman et al.[41],
Swartz et al.[42], Ekelund et al.[43], Puyau et al. [44], Trost et
al. [45, 46], Corder et al.[47], Sun et al[48]). Nilson et al. [49]
used an MTI accelerometer model 7164 (Manufacturing Technol-
ogy Inc., Fort Walton Beach, Florida, USA) to compare three of
these equations (Ekelund et al., Puyau et al., Trost et al.) in data
collected in a total of 1321 children in 4 countries during daily
life activities. They concluded that the estimations vary substan-
tially depending on the model used, with standard deviations
of 290 kcal/day. They argue that such laboratory created mod-
els can not be used interchangeably and the comparison of re-
sults should be avoided. Trost et al. compared the equations by
Trost et al, Freedson et al. and Puyau et al., and reached simi-
lar conclusions, that each equation as developed in laboratory
setting could only correctly estimate PAEE for certain types of
activities. Graauw et al. conducted a literature review on exist-
ing models for PAEE estimation, including several accelerometer
models, and is an exhaustive tool for researchers looking for in-
sights. They concluded that such models can explain up to 45%
of daily living PAEE. They indicate that tri-axial accelerometers,
that became the norm nowadays, seem to improve the accuracy.
As for adults, more equations have been proposed for esti-
mating PAEE. Crouter et al. in 2006 [50]examined the validity
of the equations proposed by several authors before: Brage et
al. [51]; Brooks et al.[52] ; Freedson et al. [40]; Heil et al. [53];
Hendelman et al. [41]; Leenders et al. [54]; Nichols et al. [55];
Swartz et al. [42]; Yngve et al. [56] and Klippel et al. [57] for
the Actigraph and Actical accelerometers, in group of preset ac-
tivities. More recently, and taking into consideration new sen-
sors and equations, Lyden et al. [58]revisited the same problem,
this time using the most common accelerometers Actigraph, Ac-
tical and RT3, and compared 11 different equations including
the RT3 proprietary equations and some of the ones taken into
consideration by Crouter et al. In a similar approach Rothney et
al.[59]asked subjects to wear 3 sensors at the same time and com-
pared the output of each sensor regarding energy expenditure.
They found very good results for vigorous activities of less than
2% differences between sensors.
The main point that comes from this extensive testing and
comparison is that current techniques produce a single average
over time of the accelerometer, thus not using the rich features
of the signal. This means that very different activities produce
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similar outputs in terms of energy expenditure estimated by the
accelerometer.
2.3.1 Gait parameters estimation
Gait parameters can be a source of information to assess bal-
ance control, functional ability but also risk of falls. Accelerome-
ters have been proposed to simply identify the moment of heel
strike [60] on leveled and inclined surface [61]walking, but also
more complex parameters as gait cycle frequency, stride symme-
try and regularity [62]. These spatio-temporal parameters can
be measured over long periods of walking, providing a signif-
icant advantage over existing systems that are only feasible in
a laboratory setting. Moe-Nilssen et al. [63, 64] estimated gait
parameters using a tri-axial accelerometer attached to the lower
back. They used standard signal filtering auto correlation anal-
ysis to estimate cadence, step length and gait regularity. They
tested their approach in up to 9m walks for a small number of
subjects.
Research has also been focusing on differences of gait features
between group ages, for instance between young and elderly[65,
66], using root mean square values of acceleration[67]. The har-
monic ratio has been proposed as an estimation of gait smooth-
ness, as defined by the ratio between the sum of even-numbered
harmonics and odd-numbered ones after finite Fourier Trans-
form [68].
When using higher sampling rate accelerometers the Butter-
worth filter, in conjunction with simple threshold-based algo-
rithms, have been used and tested in a few dozens subjects under
very controlled conditions.
Nowadays, accelerometers are not widely used as gait parame-
ter estimators. One reason for this is that proper methods to deal
with variability in gravity components of the signal have not yet
been developed. Methods exist to reduce the gravity component
and assess acceleration during locomotion, but not yet to deal
with the intrinsic variability of gravity.
2.3.2 Circadian rhythm analysis
The study of rest-wake periods has a long history in the medical
community. The introduction of robust accelerometers provided
an increase in the reliability of such studies. Prolonged measure-
ments with accelerometers spanning several cycles of rest-wake
(typically days), provides insight into chronological-biological
patterns.
The most popular method for analyzing actigraphy data for
sleep disturbance studies and circadian rhythms has been the
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cosinor analysis [69, 70, 71], in which a cosine curve with a pe-
riod of 24 hours is fit to the data by the least square method.
After the fitting process we can extract some interesting parame-
ters such as: acrophase (time of peak activity), amplitude (peak-
to-nadir difference), alpha (width of the rhythm), beta (steep-
ness of the fitted curve, which can approximate a square wave
if beta is high) and mesor (mean) of the fitted curve. Some au-
thors extended this approach by calculating the autocorrelation
index over a day cycle or the inter-day stability of the fitted curve.
Some standard statistical features such as standard deviation of
sleep time, average activity or intra-day variability have also pro-
vided evidence for several studies.
Sensors used for this purpose can detect circadian rest-activity
cycles, changes in sleep length [72, 73] and annual phase changes.
Nevertheless, given the nature of sleep, regardless of the algo-
rithms used, accelerometers have significant limitations in assess-
ing subjects with high mobility during sleep or motor disorders,
and the lack of validation between different methods and sen-
sors makes comparison or quality assurance very difficult [74].
2.3.3 Seizure detection
Godfrey et al. [75, 76] used features extracted using wavelets
analysis to classify motion from patients with delirium - an um-
brella term to denote acute generalized disturbances of cogni-
tive function, that affects up to 50% of hospitalized elderly peo-
ple - into three classes of hyperactive, hypoactive and mixed.
They used continuous wavelet transformation as well classifica-
tion trees, with good results. They first ran a study to define the
best mother wavelet for further use, based on three typical pa-
tients whose classification was known. After applying the best
wavelet, a high pass filter was applied to the coefficient in each
level. Then, counting, minimum, maximum, average and stan-
dard deviation were calculated for each level and used as clas-
sification values. In the second study a classification tree was
applied to the remaining patients. They achieved up to 96% ac-
curacy of classification
Nijsen et al. [77] used wavelets and energy analysis with the
goal of detecting seizures, in particular myoclonic seizures - a
very subtle and difficult to detect symptom - in institutionalized
patients suffering from epilepsy. The goal was to detect serious
seizures for triggering alarms or the more subtle ones for di-
agnose purpose. They used continuous wavelet transform and
short time fourier transform to typify 4 different situations: iso-
lated seizures, seizures within certain intervals of other move-
ments, slow non-seizure movement and sharp peaks in other
movements. Based on 4 sets of features (all, range, normalized,
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and range of normalized powers or coefficients) they achieved
in the best setup a sensitivity of 1 with 4 false positives (of 10
total seizures).
Fast Fourier Transformation (FFT) converts a time-based sig-
nal into its main frequency components and it is a standard
tool for time-series analysis, specially for classification of ac-
tivities. Given the high sampling rates and sensitivity of cur-
rent accelerometers, several authors have explored fractal struc-
tures in data. Fractal values extracted from maximum-likelihood-
estimate analyses and wavelets of acceleration at the trunk are
good indicators of the stability of unperturbed walking patients
suffering from Parkinson’s [78, 79] or Stroke [80, 81, 82, 83, 84].
They found that the fractal dimensions were significantly ca-
pable of detecting differences in gait related to the disease, as
for the patients with Parkinson’s disease the fractal dimensions
tended to be higher than those of healthy subjects.
2.3.4 Fall detection and prediction
Injuries caused by falls are a source of significant trauma and
loss of quality of life in the general elderly population. A fall
can be defined as a rapid postural change from upright to re-
clining to ground position, excluding the ones that arise from
a violent blow, loss of consciousness, stroke or epileptic seizure.
With current population dynamics the number of people living
alone is on the rise, and so therefore is the risk of people to
have recurrent falls, especially those in frail conditions. Gait pa-
rameters during normal walking or standing can be a source of
information leading to early warning of risk situations. In addi-
tion accelerometers can be used to determine accidental motions
caused by a fall [85].
Some fall detection applications report temporal gait parame-
ters in order to determine the actual position of the body parts,
thereby creating a detection system that can assist in clinical
interventions. In the gait detection system, the analysis is de-
pendent on the presumed pattern of body movement which is
recorded for comparison with abnomarl values obtained during
a fall. Gait cycle parameters are provided to the system in or-
der to establish an correlation between the recorded and actual
body movements [86, 87]. Ordinarily, fluctuations from the stan-
dard values are reported as possible causes of concern for the pa-
tient. The recorded values for the waves are compared with the
peak magnitudes to demonstrate the correlativity of the values.
A healthy person without motion issues has a regular pattern of
motion waves.
The first proposal of an accelerometric system was published
by Williams et al. [88, 89] incorporating along the accelerometer
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a mercury switch to identify the orientation of the apparatus. It
was based on a two stage detection algorithm with first step de-
tecting the sudden movement and impact (accelerometry) and
the final resting orientation (mercury switch), in order to reduce
the number of false positives. This approach became a commer-
cial product. Others have taken similar approaches to solve the
problem [90, 91].
Various values of body parameters are considered in the anal-
ysis some of which are step symmetry, cadence, step regularity
and stride regularity. Deviations from these parameters are an-
alyzed as possible causes of concern for the person who could
have fallen and be in need of assistance. According to Budge et
al. [92], it is possible to enhance the reporting of such fall reports
in order to manage and monitor the motion of the patients in a
remote setting. In the enhanced, real-time systems for monitor-
ing such fall cases can be important in implementing prompt
interventions in cases of emergencies where patients and older
people are followed from a distance. Morbidity is reduced in
such instances since remote deployment of assistance protocols
is facilitated and can also be exploited in the management of
care for the elderly.
According to the study conducted by Bourke et al. [93], algo-
rithmic analysis of the data obtained from possible falls by pa-
tients is dependent on the velocity and impact sustained as well
as the effective posture parameters recorded. Fall detection de-
vices fitted with accelerometers therefore internalize the various
posture settings as well as determining the impact pressure upon
falling, thereby showing important fall parameters. The accuracy
of such a device that analyzes the velocity of various movements
is important in this application since such parameters are impor-
tant in the determination of fall positions. In most devices, it is
the analysis of more than one data type that contributes to the
determination of reliable fall assessment. It is therefore expected
that a combination of all these parameters in the analysis of the
patient’s movement as well as position can be used to determine
the appropriate intervention without interpretation difficulties.
Before the implementation of such algorithms in the system is
conducted satisfactorily, certain tests are conducted on the pa-
tients’ natural systems to ensure that their motion parameters
are not confused with fallen position parameters that raise alerts
and consequent intervention protocol. Such tests such as the
Timed Up and Go (TUG) are important in establishing the data
analysis procedure based on the inherent parameters posted by
a naturally functioning system and one with motion difficulties.
Hsu and Yang [91] present a decision tree approach to iden-
tify the various human movement artificats or alterations. In
the study, the authors found out thresholds for classification of
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motion that are important in the classification of input of an
accelerometer. These can be applied in a hierarchical decision
tree for analysis for the various motion data recorded by an ac-
celerometer, identifying the actual position of the patient with
respect to normal posture data.
Transormation of the data to constitute an alarm may also in-
clude a threshold for an emergency where the alarm is gener-
ated. In such an instance, the initial threshold of the accelera-
tion is met but if the patient fell and does not stands-up again,
it is sufficient to be considered an alert value. Fall accuracy al-
gorithms that use better analysis threshold for instance include
determination of three derived parameters in order to constitute
an alarm. A sensitive axis must be defined in the detection sys-
tem and a set of accelerometers are incorporated in the device
and orthogonally worn on a strategic position on the body of
the patients. Lindemann et al. [94] used such approach in their
system, based on a ear mounted sensor. Nevertheless, given the
size and weight of the proposed system, they concluded that the
ergonomics and design of the system was a barrier.
Marschollek et al. [95] built an expert system, using classifi-
cation trees and logistic regression, based on features extracted
from accelerometry and physical activity scores. For this they ex-
tracted a set of features using spectral analysis [96]. They achieved
a classification specificity of up to 80% on retrospective predic-
tion of subjects at a risk of falling within one year.
To explore the stability of walking some authors have also ex-
plored nonlinear time series analysis, for example lyapunov ex-
ponents [97].
2.3.5 Models of health outcomes in CF and COPD
Some authors have explored the modeling of health outcomes
in chronic obstructive pulmonary disease and cystic fibrosis, but
from other variables not related to physical activity.
Troosters et al. [17] used the Sensewear device (Body media,
Pittsburgh, USA) in 20 CF patients and 20 healthy control indi-
viduals over 5-7 days, to study skeletal muscle weakness and
PA. Their results indicate a contribution of physical activity to
exercise tolerance, which is a crucial aspect of rehabilitation pro-
grams. Hebestreit et al. [11] monitored 7 days of PA, using the
MTI/CSA 7164 accelerometer (MTI Health Services, Fort Wal-
ton Beach, USA), and correlated the results with exercise capac-
ity. They found that average daily accelerometer count, moder-
ate and vigorous PA independently explained part of the vari-
ance in maximal oxygen uptake, contributing to understanding
the importance of rehabilitation programs in CF. Fournier et al.
[18] recruited 15 CF patients, in whom they measured PA for 7
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days, and correlated the results with pulmonary function and
exercise tolerance. To study energy expenditure in CF patients
during Pseudomonas aeruginosa-related pulmonary exacerba-
tion, Béghin et al. [16] assessed PA in 16 children, but only for
24 hours, including a normal day at school. In this group they
found no significant decrease of PA in the time between two in-
travenous antibiotic therapy sessions. In contrast, Wells et al. [98]
evaluated the output of the Actigraph accelerometer over two
weeks in 14 patients and compared data with the habitual activ-
ity estimation scale and a diary, concluding that a questionnaire
is a reliable instrument for estimation of PA levels in patients
with CF.
There is little research into the use of machine learning and
modeling of health outcomes or health parameters from accelerom-
eter and PA data. One of the limiting factors for this is the need
for high sampling rates and long periods of measurement in or-
der to extract robust features from the data.
Several studies [99, 100, 101, 102, 103] have investigated the
forecast of exacerbations in COPD, but with only partial success.
Marin et al. [99] and Ong et al. [102] proposed using the BODE
index, a composite marker of COPD disease, to predict the prob-
ability of exacerbation within a year period. Miniati et al. [100]
also aimed to predict exacerbations over the period of one year
but using the C-reactive protein as source of information. Jensen
et al. [103] looked at the various physiological dimensions, such
as blood pressure, as predictors for exacerbation on a scale of
several months, using data that was collected by several medical
sensors in a telemedicine project. Other authors have explored
the predictive capacity of PA in COPD, but focussing on the
mortality rate [104] or the overall health status of the patients
[105]. Garcia-Rio et al. [104] found that the time until first admis-
sion to hospital due to exacerbation was linked to lower physical
activity levels, which hints at a relation between PA and exacer-
bations.
2.3.6 Summary
The most common use of accelerometers in medical applications
is still the estimation of PA in patients or healthy subjects. This is
conceptually the simplest of the applications and comprises the
conversion of the acceleration recorded into a measurement of
total physical activity carried out. Increasing amount of research
and effort is going into new fields of application. Sleep medicine
can benefit from the type of monitoring provided by small and
unobtrusive sensors.
More complex and robust applications have been developed
as well, from estimation of gait parameters to the calculation
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of fall risks. In order to provide reliable results these aproaches
probably need either increased accuracy of the hardware avail-
able, or extensive research into better methods of analyzing the
data.
3
M AT E R I A L S
This chapter presents the decision-making process, the materi-
als and methods used in the research. We present off-the-shelf
sensors and their essential characteristics and details. We also in-
troduce the computational methods used for signal processing,
model construction and analysis of the results.
At the start of our studies we defined crucial criteria for sen-
sor selection: sensors had to be off-the-shelf, readily available
and validated sensors. We couldn’t develop or support the de-
velopment of new sensors, even if they would provide technical
advantages for the research. The timeframes of the research and
goals would make it unfeasible. The commercial offer of such
devices is robust nowadays, with several dozen manufacturers
proposing different solutions, which creates a competitive envi-
ronment with constant evolution. We have no expertise in de-
signing of electronics and have no intention to validate sensors,
an essential step if we had opted to develop our own hardware.
After detailed analysis of off-the-shelf sensors we decided on
the use of a small set for feasibility studies in the first instance.
3.1 sensors
Modern devices are small, lightweight and can be attached at the
body using elastic belts with minimal burden for the participant.
The hip is the preferred place of attachment, as it is the centre of
the body mass. Devices should be worn for at least seven days
to cover intra-week variations between work days and weekend.
Its size and water resistance allow the participants to wear the
device for several days continuously without the need to take
it off. This reduces problems with compliance and non-wearing
periods.
Table 3.1 shows a comparison of key aspects of several off-the-
shelf sensors. This is the result of our exploratory assessment of
several sensors on the market. It provides an easily accessible
tool for comparison and facilitates decision-making on which
sensors to use on a given research project.
3.1.1 GT1M and GT3X
The GT1M (Actigraph, Pensacola Florida, USA) is a uni-axial ac-
celeration sensor with micro-electromechanical technology. The
GT3X (Actigraph LLC, Pensacola Florida, USA) is a tri-axial
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Table 3.1: Main characteristics of readily available off-the-shelf sensors
for physical activity and heart rate measurement (updated
March 2010)
Figure 3.1: GT1M and GT3X. Both share the same casing design
acceleration sensor. Both use a Micro-Electro-Mechanical Sys-
tems (MEMS) technology and have a sampling rate of 30Hz. The
firmware can be configured to record steps, activity counts, incli-
nation. Although the sampling rate is 30Hz, configuration allows
recording on samplings of 1 second to 1 minute or raw data, be-
fore or after filtering. The filter, implemented in the firmware
is, according to the manufacturer, a bandpass between 0.25 to
2.5 Hz. The inclinometer measurement can be used for identifi-
cation of moments when the sensors are not worn. The battery
is built-in, with capacity of up to 30 days of recording, with
safe duration of 21 days. They are small and lightweight (3,8 x
3,7 x 1,8 cm, 27g). The software provided by the manufacturer
supports several processing algorithms, including the estimation
of energy expenditure through several equations. Both sensors
have been validated in medical applications for estimation of en-
ergy consumption [106, 52, 40, 56]. Vries et al[107] reported that
the ActiGraph series was the most studied activity monitor, and
many studies have validated its reliability and performance. Fig-
ure 3.1 shows the external appearance of both GT1M and GT3X
sensors.
3.1 sensors 29
Figure 3.2: Stayhealthy RT3, a tri-axial and wide use sensor
3.1.2 RT3
The RT3 (Stayhealthy, Monrovia, CA) is designed as a complete
activity recording and measurement system for clinical and re-
search applications. It uses piezoelectric accelerometer technol-
ogy and provides data as a three-dimensional vector and a vec-
tor magnitude. It is usually worn on the waist, as a holster is
provided for the attachment. For the calculation of the calorie
consumption estimation or the metabolic equivalent units, the
weight of the subject is taken into consideration. The software
provides an estimation of metabolic activity units taking into
consideration the activity counts and age, gender, height and
weight of the person. It is able to record three hours of acceler-
ation data with a resolution of 1 second or 21 days at 1 minute
resolution. It has been validated in medical applications for en-
ergy consumption estimation [48]. The RT3 sensor, shown in fig-
ure 3.2, also replaces the previous version TritracR3D, which has
been widely used in a number of studies and research applica-
tions. It uses standard AAA batteries that need to be removed
to be replaced or recharged. This causes total loss of memory
contents and it is a potential source of data loss if the battery
is removed by accident during measurement or before data is
downloaded from the sensor. The interface of the RT3 to the
computer is an outdated RS-232 port, with a docking station as
direct interface to the sensor. The docking mechanism is highly
unreliable, causing a high number of connection errors. Its di-
mensions are 7,1 x 5,6 x 2,8 cm and it weighs 65,2g.
3.1.3 GAITRite
The GAITRite walkway is a roll-up carpet containing many sen-
sors for analyzing the gait of a person. Its active area, a 365 cm
long and 61 cm wide measurement zone, is composed of 6 sensor
pads, with each being 155 square cm. One sensor pad contains
30 materials
Figure 3.3: Polar RS800CX heart rate sensor (not to scale)
2304 sensors arranged in a 48x48 grid and each of the sensors is
placed on a 1.27 cm center. While a person walks over the walk-
way, those sensors collect information about the footprints, the
step length, the rhythm, etc. The GAITRite program stores these
data into a structured database.
3.1.4 Polar RS800
For heart rate we used the Polar RS800CX sensor. It consists of
a strap-on chest unit and a wrist unit. The chest unit contains
electrodes in a textile band and a wireless transmission unit.
Polar RS800, shown in figure 3.3, is a recent model and was not
used, to our knowledge, in any scientific study to date. Accord-
ing to the manufacturer the RS800 model is functionally equiva-
lent to the S810 model, which was independently validated.
3.2 subjects
Recruitment of subjects and patients for all the studies was con-
ducted with different cooperation partners, namely the KORA-
Age study run by HelmholtzZentrum in Munich, the pneumonology
division at Ludwig Maximilians University hospital and Klinik
Bad Reichenhall.
3.2.1 Studies
As presented earlier, we conducted a total of 4 studies with dif-
ferent goals and subjects. Table 3.2 presents an overview of the
different studies, the goals, criteria and subjects for each one of
the studies. These studies developed chronologically in the order
presented, and also in terms of subjects involved.
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Table 3.2: Studies in this thesis, their goals, subjects and criteria
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Table 3.3: Relevant characteristics of the 7 subjects in the feasibility
study
Age Gender Activity level Height (cm) Weight (Kg)
22 F 5 178 59
25 M 3 181 70
56 F 4 162 70
62 M 4 178 77
78 F 4 151 78
85 M 1 160 65
86 M 2 163 76
3.2.2 Feasibility study
We asked 7 people to wear the sensors while performing their
daily life activities and report their opinions on the sensors, namely
the comfort, ease of use and problems if any. We did not request
any information on their health status as it was considered irrele-
vant for the objectives of this study. Their essential characteristics
are shown in table 3.3. In the table the activity level is a subjec-
tive assessment of their activity level in daily life in a scale of 1
to 5, with 1 being the lowest.
Our goal in the first feasibility study was not to use the mea-
surements for a quantitative assessment, but rather to perform
a qualitative evaluation of the sensors in order to assess their
feasibility for bigger studies. In particular, we were interested
in checking out limitations and identifying problems that arise
when using the sensors over long measurement periods.
3.2.3 Chronic Obstructive Pulmonary Disease - Klinik Bad Reichen-
hall
We recruited, in Klinic Bad Reichenhall, 58 patients (35 males
and 23 females) diagnosed with severe smoking related COPD,
undergoing Long Term Oxygen Therapy, and admitted to a pul-
monary rehabilitation program. All patients had a diagnosis of
COPD related to smoking, in stage IV according to GOLD guide-
lines. See table 3.4 for detailed clinical indicators for the recruited
patients. We asked them to wear a GT1M sensor at leg and arm
and a RT3 sensor at the hip, from getting up to going to bed, for
a period greater than a week. Patients with type 2 respiratory
failure or with less than four days of accelerometry data for two
of the locations were excluded from the study, leaving us with a
total of 52 valid datasets for further processing. All procedures
were approved by the relevant ethics commission.
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Figure 3.4: Photo showing one of the COPD patients wearing the arm
and hip sensor
The photo in figure 3.4 was taken during the study, and rep-
resents one of the subjects wearing the arm and hip sensor (leg
sensor not visible).
3.2.4 Cystic Fibrosis - Klinik Innenstadt
We asked 15 CF out-patients to participate in the study whose
details are shown in table 3.5. The interview took place during
their routine consultation with their doctor at the clinic. Only
patients aged >18 years and in a stable clinical condition were
included. Participation was voluntary, with no compensation. A
written informed consent was obtained from each participant,
and the Ethics Committee approved the study protocol. Besides
the CF patients we recruited 10 age-matched healthy subjects
without known history of disease or condition influencing their
PA, as control subjects. In order to provide useful feedback to
the patients and to increase their motivation to participate in
the study, the acquired data was offered to inform the patients
about potential findings indicating a restless leg syndrome. An
overview of the participating CF patients’ health status is given
in table 3.5. One of the patients has a clearly higher FEV1%pred.
assessment than the average, most likely the result of her/his
younger age, and thus her/his lung capacity hasn’t been severely
affected by the disease.
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Table 3.4: Characteristics of the participating COPD patients
Variable Average±SD
Age (y) 62.2±9.6








To obtain information on different aspects of movement, we
used the uniaxial accelerometer Actigraph GT1M, placed at the
ankle, and the tri-axial accelerometer RT3 placed at the hip. The
sensors were configured to record activity once a minute.
3.2.5 KORA cohort and KORA-Age study
Two hundred subjects from the KORA-Age study were screened
for participation. The study center was responsible for recruit-
ment of subjects in the context of the KORA-Age study. After
agreeing to participate each subject was asked to visit the re-
search laboratory at LMU. We provided the staff at LMU with
individual sets of sensors as needed. Each set consisted of the
sensors themselves, fully configures and with charged batteries,
a postage paid envelope for returning the sensors to our labo-
ratory and an information sheet, date of return and contact for
questions. See appendix iv.
Participants are members of the KORA cohort, a subsample
from the epidemiological cooperative health research in the re-
gion of Augsburg study [21], who were born in the year 1943 or
before, and who were assigned to the lung function and physical
activity examination sub-project, based on previously measured
spirometry in the KORA study center Augsburg.
The inclusion criteria were: older than 65 years, without known
pulmonary disease (COPD, asthma or bronchitis). Of these, 191
subjects agreed to participate and we recorded a total of 1696
valid days with a sensor wear time of x>3 hours. Of these, 179
subjects provided a full week of data, with 2 drop-outs who wore
the sensors for less than a day. The subjects wore the sensors
from 7 AM till 9 PM, 12 hours on average, including a mean of
9 short periods of non-wearing.
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Table 3.5: Characteristics of the participating CF patients. Characteris-
tics (FEV1 = forced expiratory volume in one second, PaO2
= arterial oxygen pressure, PaCO2 arterial pressure for car-
bon dioxide, %pred = values as percent of predicted normal
values)
ID Age Height Weight FEV1 FEV1%
pred.
PaO2 PaCO2
P1 40 175 66 1.49 39 72,2 38.1
P2 25 179 67 3.11 81 83.0 33.4
P3 26 166 50 1.95 51 94.0 41.0
P4 21 160 61 4.34 119 86.4 37.2
P5 26 184 74 1.91 41 75.0 40.3
P6 31 180 55 3.27 75 84.3 40.2
P7 30 157 49 2.13 75 77.0 33.3
P8 35 190 85 4.14 89 76.8 37.6
P9 36 169 62 1.69 46 50.2 40.3
P10 25 160 57 1.42 39 68.0 42.1
Avg 29.5 172 62.6 2.55 65.5 76.7 38.4
Table 3.6: Characteristics of the KORA-Age participating subjects. Val-
ues are average±standard deviation
All Male (n=92) Female (n=98)
Age (y) 75.1±6.6 75.3±6.4 74.9±6.8
Weight (kg) 75.2±11.7 79.4±10.2 71.3±11.7
Height 164.1±9.0 170.3±6.6 158.3±6.8
BMI (Kg/m) 28.0±4.0 27.4±3.3 28.5±4.5
The KORA-Age study was approved by the Ethics Committee
of the Bavarian Medical Association. Written informed consent
has been obtained from the participants and all investigations
have been conducted according to the principles expressed in
the Declaration of Helsinki.
3.3 summary
We planned the recruitment of subjects following a logical pat-
tern of starting with a small group of healthy subjects known
socially to the research team and later recruiting larger groups
of subjects. We started with young CF patients, expecting that
due to their younger age they would be motivated to participate
in the studies and then moved to older COPD patients. Later
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we cooperated with the KORA-Age study with a large group
of subjects, which posed different challenges, due to size and
recruitment strategy.
During these studies we established strong and long-lasting
research relationships with the medical partners.
4
M E T H O D S
In this chapter we present the operating procedures for the han-
dling of the sensors and the software methods implemented to
process the data collected. We present general aspects of the re-
search setup, namely handling of the sensors and software tools
used, and then the experimental methods for the core studies
relating to the research questions. I did all the software analysis
and development presented in this chapter, after discussion and
feedback from the team and our partners.
4.1 sensor handling
For all the studies in this thesis we adopted a very similar pro-
tocol for handling the sensors and delivery to the subjects. The
main difference among studies was the method for collecting the
sensors, either by post or in person.
The sensors were prepared at the laboratory, by charging the
batteries, initializing the correct configuration and assigning track-
ing number to each one. After this preparation they were assem-
bled into sets of sensors and information sheets to the subjects,
see the information sheets in appendixiv. The sets were then
delivered to the subjects in the interview process, when an ex-
planation of the study and the sensors was also given. After this
the measurement period started and the subjects took care of the
handling of the sensors themselves. When the period finished, or
in case of drop-out, the sensors were returned to the team. In the
CF study and KORA-Age the return of the sensors was carried
by post, in envelopes that were pre-paid and pre-addressed back
to the laboratory. In the COPD study as the patients were in the
clinic the whole period they returned the sensors to the medical
or nursing staff, and they were later collected by a team member.
After the sensors with data were returned to the laboratory
all data was downloaded to a central repository and stored ac-
cording to a standard procedure. We investigated all suspected
sensor failures, namely when data was missing or showing odd
values. The probable cause of failure and the tracking number
of the problematic sensor was recorded, so we could assess if a
given sensor had a permanent or recurring failure in order to
put them aside.
The CF study provided us very relevant feedback on the us-
ability of the sensors, namely the locking mechanism of the straps.
This made us replace the standard, manufacturer provided, clip
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mechanism with a velcro strap. This provided a significant im-
provement on the usability of the sensors for the remaining stud-
ies.
I formalized the operating procedures and information sheets
for the patients, after discussing the needs with the team mem-
bers and after initial feedback from previous studies.
4.2 matlab
We opted for implementing a toolbox of computational routines
given the large datasets that our projects would generate. This
was driven by the need to implement standard though highly
computationally complex methods, and the need to repeat a set
of tasks numerous times for each subject in the dataset. After
checking and comparing the features, advantages and disadvan-
tages of several commercially available tools, we decided to im-
plement the toolbox in Matlab.
Matlab, which is developed by MathWorks inc (Natick, MA,
USA), is a numerical computing environment and a program-
ming language. It can be used for matrix manipulations, plot-
ting functions and data, implementing algorithms, creating user
interfaces and interacting with programs written in other lan-
guages such as for example C, C++, Java and Fortran. Having
native array operations that work without explicit loops, gives
these operations a good execution time. Vectorisation is there-
fore an effective way of optimising the runtime of a function or
script; the speed can be improved by a factor of 10 or more. The
speed of a function or script can be improved by 10 times or even
better. We used Matlab version 7.0.4 (R14SP2) running on GNU
Linux (Ubuntu 10.4 and 12.04) and MacOs X (10.6).
The simplicity of the code needed for most tasks and the signif-
icant speed over conventional programming tools were the main
factors to choose Matlab as the platform for implementation of
the algorithms for this thesis.
4.3 cystic fibrosis patients profiles
From the accelerometer daily data from 6AM to 10PM we ex-
tracted 8 features from a scatter plot of the filtered values mea-
sured by each sensor. The scatter matrix used for the feature ex-
traction consisted of consecutive values that were plotted against
each other. For each two consecutive activity measurements Xi
and Xi+1 , at minute i and i + 1, Xi is the coordinate on the x-axis
and Xi+1 is the coordinate on the y-axis. The features were: coor-
dinates of the centroid of all points (median coordinate along X
and Y axis), proportion of points within 5% of the area around
the centroid (percent relative to maximum area defined by the
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signal amplitude), density of points in each of the four quad-
rants (also defined by the maximum area of the signal ampli-
tude) and average distance of points to the centroid. We choose
these features after comparison of all the scatter plots and iden-
tifying visual distinctions between patients and controls. These
features were used as input for a feed-forward neuronal network
with 20 hidden neurons. The NN was trained to discriminate
between patients and control subjects using the leave-one-out
method which is a standard cross-validation scheme for small
data sets. Algorithm 4.1 represents the pseudo-code for the fea-
ture extraction. The first step is the creation of the scatter matrix,
as explained above, where two consecutive measurements are X
and Y coordinates of each point in the matrix. From this matrix
we check if each point is inside a square, comprising 5% of the
total plot area, around the centroid of all points. Next we check
which quadrant of the plot the point is. Last we calculate the
distance from the origin to the point, to calculate the average
distance of all points. The extracted features are normalized to a
percentage of total points.
4.4 copd exacerbation classification
In this first approach to the overall prediction problem of exacer-
bations we focused on the task of classifying exacerbation days
from control days. We explored several features, some of wich
are commonly used in signal processing and others have been
previously used in classification tasks of accelerometer data [62,
108-113].
For a given day n, we extracted features from the data set of
day n-w, ... n-1 and n, except the day when the patient was diag-
nosed. With w as a feature window indicating how many days
preceding the n day were used in the feature extraction. We con-
sidered that data from the day before diagnosis of the exacerba-
tion could be already influenced by the onset and so cannot be
safely considered a non-exacerbation. We extracted a total of 20
different features from the accelerometer data for classification.
They include features that focus on the characteristics of the PA
data from each individual sensor separately (set 1), frequency
and time-scale features of each sensor that are commonly used
in signal processing problems, and have been previously used
in the classification of accelerometer data, specially in the scope
of activity detection (set 2). The last set is composed of cross-
information of data collected at different body parts (set 3). See
table 4.1 for details of the extracted features.
For all the above features we calculated them twice with time
window w of 3 and 2 days before the feature day. We explored
the best time window by running tests with window values rang-
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Algorithm 4.1 Pseudo-code for the feature extraction phase in
the CF data
for i 1 to numberSubjects
scatterMatrix = createScatter(subjectData)
centroid(1) = sum(scatterMatrix(1)) / length
centroid(2) = sum(scatterMatrix(2)) / length
for j 1 to lengthMatrix(1)
if scatterMatrix (j) is inside( square(0.05, centroid(1),
centroid(2))
count= count+1
if scatterMatrix(j) inside (quadrant1)
Q1 = Q1+1
if scatterMatrix(j) inside (quadrant2)
Q2 = Q2+1
if scatterMatrix(j) inside (quadrant3)
Q3 = Q3+1
if scatterMatrix(j) inside (quadrant4)
Q4 = Q4+1
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Algorithm 4.2 Pseudo-code for the feature extraction phase of
COPD data
for i 1 to numberSubjects
for w 2 to 3
for d w to numberDays(subjectData)
















feature_HLC(w) = correlation(windowData.leg, windowData.
hip)
feature_HAC(w) = correlation(windowData.leg, windowData.
arm)











ing from 1 day to 5 days (half the recorded period). Given the
time frames of the exacerbation episodes and the amount of data
recorded before the onset event, we found that smaller windows
would not carry significant information and larger values would
reduce the number of possible features too much. We have for
instance the features MAX2 and MAX3, respectively the maxi-
mum value calculated over the data series from two and three
days prior to the focus day. Besides these three sets of features,
we further merged all features into a large feature set and se-
lected the most relevant ones by applying the sequential feature
selection algorithm. Of the original 90 features, the algorithm se-
lected 17 and we run the classification methods based on them.
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Table 4.1: Features extracted for the classification of exacerbation
episodes in COPD
Feature name Description Set
Mean (M)
We used Matlab implementations of these













Provides an estimation of the movement





Indicates the similarity of the data over a
period of 24 hours to the next period. It is
an estimation of the changes of activity






Similar feature as the previous one but
after the original data as been smoothed




Calculates the average frequency of the




Calculates the most common frequency in
the movements. It indicates the nature,
fast of slow, of the movement.
Energy (E) Calculates the energy normalized over
each sub-band of the spectrum of the data
Linear correlation
coefficient (LCF)
The frequency domain linear correlation
coefficients reveal the presence of a strong
correlation between similar movements
Cross-correlation





This feature indicates the extent of the
offset, if any, between the two data series
from different sensors
3






An estimation of the similarity between
the data from two different sensors,
indicating the coordination of movements
between different body parts
After extracting all the features we implemented three differ-
ent classification methods to apply to the datasets. They were
logarithmic regression, support vector machines (SVM) and feed-
forward neural network (NN) with 50 neurons in the hidden
layer. We established the configuration for the neural network af-
ter running a test with 5, 10, 20, 50 and 100 neurons and finding
the most robust one. We used a 10-fold cross validation method
for assessing the robustness of the algorithms, given the low
number of test and control cases in the dataset. For each algo-
rithm and feature set we plotted the ROC curve, averaged over
all of the 10 runs. These methods are standard machine learning
methods and have been previously used in the classification of
accelerometer data, for instance in [111, 90, 114, 115, 116, 117,
118].
4.5 parameters of pa for lung research
As part of the cooperation with KORA-Age we implemented the
necessary methods and extracted a set of basic features from the
accelerometer data. This data was then submitted to a central
database of the study and made available to all other coopera-
tion partners. The definition of the set of features to be extracted
was the result of a careful discussion with the medical partners
and consisted of 42 features comprising different aspects of the
physical activity. See table 4.2 for details.
After importing the data from .csv files into Matlab we ap-
plied an adjusted algorithm of Hecht et al. [119] on the cohort
data based on the triaxial VMU representation to determine the
wearing time. This algorithm was originally developed for the
RT3 accelerometer, and so the authors chose a threshold Vector
Magnitude Unit (VMU) value of five because it was the highest
value recorded by the RT3 when resting on a stationary surface.
We adapted the algorithm using a VMU value of zero, instead of
five, because GT3X did not show any noise when resting, that is
no values higher than zero.
To check if the algorithm is valid, we plotted the data of wear-
ing time for visualization (leg and hip). Two researchers ana-
lyzed the plots independently to identify the days the package
with sensors was in the postal system and thus still recording un-
usable data. The plot typically has a sparse and irregular spike
pattern during the transport period (see figure 4.1). For each
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Figure 4.1: Plot showing the different pattern for accelerometer data
during transport
subject both researchers noted the number of days to be consid-
ered for analysis. In case of disagreement consensus had to be
reached, with the default rule to drop the day in case of doubt.
In the next step the days considered as valid in the previous step
were cut out and new plots were generated with the data before
and after this cutting out.
Table 4.2: Features extracted from PA data for the KORA-Age study
Name Description
totalHWearL Total number of hours sensor was worn at
the leg, including short time gaps of non
wearing. Leg.
totalHWearH Total number of hours sensor was worn at
the hip, including short time gaps of non
wearing. Hip.
startWearHL Hour of day when sensor started to be worn.
Leg.
startWearML Minute of hour when sensor started to worn.
Leg.
startWearHH Hour of day when sensor started to be worn.
Leg.
startWearMH Minute of hour when sensor started to worn.
Hip.
nonWearPerCntL Number of periods during the day that the
sensor was not worn. Leg.
nonWearPerCntH Number of periods during the day that the
sensor was not worn. Hip.
avgNonWearL Average duration of non wearing periods.
Leg
avgNonWearH Average duration of non wearing periods.
Hip
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averageActL Average of activity during the periods
sensor was worn. Leg.
standardDevL Standard deviation of activity during the
periods sensor was worn. Leg.
averageActH Average of activity during the periods
sensor was worn. Hip.
standardDevH Standard deviation of activity during the
periods sensor was worn. Hip.
max1HMovAvgH Maximum value of 1 hour moving average
function over activity. Hip.
max1HMovAvgL Maximum value of 1 hour moving average
function over activity. Leg.
HMax1hMovAvgL Approximate hour of day when 1hour
moving average reached maximum. Leg.
MMax1hMovAvgL Approximate minute when 1hour moving
average reached maximum. Leg.
HMax1hMovAvgH Approximate hour of day when 1hour
moving average reached maximum. Hip.
MMax1hMovAvgH Approximate minute when 1hour moving
average reached maximum. Hip.
avgDailyMETL Average of MET for periods when sensors
where worn. Leg. Integer. Range: 0-...
avgDailyMETH Average of MET for periods when sensors
where worn. Hip.
sedentaryMETL Percentage of time spent in sedentary levels,
according to MET calculation. Leg.
lowMETL Percentage of time spent in low levels,
according to MET calculation. Leg.
mediumMETL Percentage of time spent in medium levels,
according to MET calculation. Leg.
highMETL Percentage of time spent in high levels,
according to MET calculation. Leg.
sedentaryMETH Percentage of time spent in sedentary levels,
according to MET calculation. Hip.
lowMETH Percentage of time spent in low levels,
according to MET calculation. Hip.
mediumMETH Percentage of time spent in medium levels,
according to MET calculation. Hip.
highMETH Percentage of time spent in high levels,
according to MET calculation. Hip.
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sedQrtActL Percentage of time spent in sedentary
activity levels, from maximum activity
quartiles. Leg.
lowQrtActL Percentage of time spent in low activity
levels, from maximum activity quartiles.
Leg.
medQrtActL Percentage of time spent in medium activity
levels, from maximum activity quartiles.
Leg.
highQrtActL Percentage of time spent in high activity
levels, from maximum activity quartiles.
Leg.
sedQrtActH Percentage of time spent in sedentary
activity levels, from maximum activity
quartiles. Hip.
lowQrtActH Percentage of time spent in low activity
levels, from maximum activity quartiles.
Hip.
medQrtActH Percentage of time spent in medium activity
levels, from maximum activity quartiles.
Hip.
highQrtActH Percentage of time spent in high activity
levels, from maximum activity quartiles.
Hip.
longPrdSedL 3ongest period of time in sedentary
(quartiles) activity. Leg.
longPrdSedH Longest period of time in sedentary
(quartiles) activity. Hip.
4.5.1 Code validation
All the features we implemented were defined after a discussion
with the medical team in the study, and naturally there was the
need to test the developed code. For this validation, we adopted
a two-step strategy: first, we tested with simulated time series of
a known pattern, and then we checked the results of a small set
of subjects for plausibility of the output.
We generated five different artificial time series, each one day
long, containing different patterns: Constant value of 10 ( fig-
ure 4.2 ); pattern of 20 minutes zero and 10 minutes value 100
(figure 4.5); pattern of 30 minutes zero and 30 minutes value 100
(figure 4.6); sequence 1 to 100 repeated (figure 4.4 ); normally dis-
tributed random values of average 100 with standard deviation
50 (figure 4.3). Each of the time series aimed to check a particular
4.5 parameters of pa for lung research 47
Figure 4.2: Artificial time series for test with constant value 10
critical aspect of the scripts, such as the correct implementation
of the algorithms for wearing time by Hecht et al., the correct
values for predictable outputs or the statistical coherence of the
outputs for the random inputs. For the second step we selected
10 random subjects from the dataset, plotted the data at random
days, and checked the output of the scripts for plausibility. This
included, for example, checking the number of estimated hours
of sensor wearing (less than 24 hours, coherent with the data
plot), assessment of mean and standard deviation of values to
the expected value from the plot, and cross-checking of depen-
dent variables for accurate values, such as start time and end
time of wearing to number of hours of wearing.
Figure 4.2 represents the constant value 10 which allows us
to do the most basic test of the code, expecting that the wear-
ing time must be at 100% and a constant value for physical ac-
tivity quantification. Figure 4.5 depicts a pattern of 20 minutes
with value zero followed by 20 minutes of value 100 allowing to
test the wearing time estimation according to Hecht et al. The
interval of 20 minutes was chosen because it is below the thresh-
old in the algorithm. Figure 4.6 is very similar to the previous
one, but rather uses a interval of 30 minutes, cross testing the
wearing time implementation. Both of these tests also provide
data for the remaining features, as their values are deterministic.
The test in figure 4.4 is intended to test the algorithms across a
larger range of values, from 0 to 100, but maintaining a deter-
ministic output for easy analysis. The last test, seen in figure 4.3,
comprises a large range of possible values, from 0 to 100, but
generated randomly. This provides a more complex test where
the expected output can’t be pre-estimated, but rather only esti-
mated values can be observed or not.
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Figure 4.3: Test time series with normal random distribution, average
100 and standard deviation 50
Figure 4.4: Artificial time series consisting of a sequence 1 to 100 re-
peated
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Figure 4.5: Time series with pattern of 20 minutes value 0, 20 minutes
value 100
Figure 4.6: Time series with pattern of 30 minutes value 0, 30 minutes
value 100
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4.6 critique of the methods
We used standard feature extraction and classification methods
in the CF and COPD study. We are aware that better feature
extraction process can result in improved quality of the final re-
sults. Nevertheless, as we are dealing with a first attempt at the
classification of exacerbation days, no direct prior experience of
research exists.
The features extracted for the KORA-Age study are very gen-
eral and of a wide nature. Although they are inspired by previ-
ous research, it remains open if they are the most relevant for
the future needs of the cohort partners. This poses a challenge,
because future needs can change. For this reason we stored all ac-
celerometer raw data, so that if future needs arise, more features
can be extracted as requested. Still, because of the KORA-Age
internal structure this may prove a very long process.
For the classification tasks we choose to use three standard al-
gorithms (logarithmic regression, neural networks and support
vector machines) based mostly on previous published research
on classification of accelerometer data. These are either very sim-
ple, without configurable parameters, or widely used in similar
tasks, making them reasonable choices. Nevertheless we can’t
state that other algorithms are able or not to achieve better re-
sults.
We didn’t conduct formal and extensive research on the usabil-
ity aspects of sensor use. The conclusions are related to the team
experience and summarize the challenges we faced. We believe
that other researchers can have significantly different results, de-
pending on subjective factors and criteria.
4.7 summary
We opted on all the studies to use only off the shelf and vali-
dated sensors, choosing the RT3 and GT1M and GT3X family
sensors as generic solution. The analysis of data comprised the
extensive use of Matlab, as it is a robust and mature computa-
tional platform providing essential implementations of common
tools. From the sensor data we extracted different sets of features,
according to the needs of the study, that were later used. The
classification of CF and COPD patients, was achieved with the
use of standard machine learning techniques, such as neural net-
works and support vector machines. A large set of features was
extracted, from the KORA-age study data, tested and submitted
for later usage by all the cooperating partners in the study.
5
R E S U LT S
This chapter presents the results related to the main research
questions of this thesis. The chapter presents results of the clas-
sification of patients with CF and controls, the classification of
different days on COPD and the extraction of PA parameters for
the KORA-Age project. In the scope of this work I used several
machine learning methods for the classification of the data from
CF and COPD studies, with data fed to them from a feature ex-
traction step, using standard features. For the KORA-Age data
I discussed with the partners and implemented a large set of
features that were later submitted and made available to all the
project partners. We also present results regarding the usability
questions and acceptance of the sensors.
5.1 cf classification
The results from our study with CF patients contribute to an-
swering question RQ1, RQ4 and RQ5. This section presents the
results relevant to RQ2 and RQ5, relating to the study of exacer-
bation episodes in cystic fibrosis and the best methods to classify
data collected from accelerometers during long term monitoring.
Figure 5.1 shows the PA time series for one CF patient, the
only one that experienced an exacerbation during the study pe-
riod (exacerbation period marked), where the exacerbation pe-
riod is marked. Unfortunately, PA had not been measured for a
long enough time in the days preceding the exacerbation. Nev-
ertheless there appeared to be a prolonged drop in the activity
level during the exacerbation episode irrespective of the shorter
drops seen afterwards. This renders it a sensible aim to further
explore the potential of using PA as an early predictor of exacer-
bations.
We explored several techniques to model the individual pa-
tients’ PA profiles. As an example, figure 5.2 shows an exploratory
scatter plot of the distance between two consecutive measure-
ments, from two CF patients and one control subject. The top
images are the patients and the bottom one is the control sub-
ject. These plots show distinct physical activity profiles among
subjects and even hint at a distinction between CF patients and
controls. They show the patterns of physical activity change at
1-minute intervals. Higher density of points around a central
point indicates a smooth pattern of movement with low ampli-
tude changes along time. On the other hand, sparse plots in-
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Figure 5.1: Plot of the recorded data for the only CF patient undergo-
ing an exacerbation
Table 5.1: Confusion matrix for PA modeling of Cystic Fibrosis patients
and controls using neural network and 8 features extracted
from accelerometry data
Patients Controls Sum
NN predicted patient 8 1 10
NN predicted control 2 9 10




dicate highly dynamic changes of activity. The location of the
highest density cluster along the diagonal indicates the overall
intensity of PA.
Based on the scatter plots above, we extracted several features,
as introduced in the previous chapter, and used a NN to distin-
guish patients from control subjects. The NN could be success-
fully trained by the filtered leg sensor data, achieving an accu-
racy of 85%, with sensitivity of 80% and specificity of 90%. The
F-score for this setup was 84% and the Area Under the Curve
(AUC) 81%. By contrast the NN trained with data from the hip
sensor achieved an accuracy of 63%, with sensitivity of 65% and
specificity of 70%. The confusion matrix for the NN trained with
leg data is shown in Table 5.1.
5.2 classification of days in copd
The results from the study regarding the classification of exac-
erbation days in COPD contributes to answering questions RQ4
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Figure 5.2: Scatter plot showing different activity profiles for patients
and control subjects
and RQ5. Providing information to the viability of detecting and
classify exacerbation days and non-exacerbation days based on
the accelerometer data, exploring several classification methods.
In Figure 5.3 we can see the ROC for the three classification
algorithms when using feature set 1, composed of common fea-
tures used in data mining. We can observe that the support vec-
tor machine has the best performance with an AUC of 74%. The
logarithmic regression algorithm has a very poor performance.
Overall we can affirm that this set of features does not provide
useful classification information.
Figure 5.4 shows the ROC of set 2 of features, as described
in the methods chapter it is composed of features based on the
frequency domain of the time series, where we can see an over-
all improvement of the classification power of the features and
methods over set 1. SVM achieves the best results as well, with
NN unable to improve the AUC with the new feature set.
In Figure 5.5 we present the performance of the three algo-
rithms for set 3 of features, comprising features that focus on the
relation of the data recorded at different body parts. The SVM
classifier is the best classifier for this feature set. The logarithmic
regression and NN achieve very similar AUC. These results in-
dicate that the differences or similarities of movement between
body parts hold useful information.
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Figure 5.3: ROC curve for Feature Set 1
Table 5.2 shows the AUC for the 4 feature sets and the three
classifiers for the COPD dataset. Overall SVM achieved the high-
est AUC while logarithmic regression showed the lowest perfor-
mance. Overall the results indicate a fairly low classification ca-
pacity of the different algorithms. With the best classifier, SVM,
using all the features, we can achieve 100% sensitivity, with a
specificity level of 85%, see figure 5.6. That is, to have all exac-
erbation episodes correctly classified we will have 17 out of 20
of the non-exacerbations classified as exacerbation episodes - i.e.
as false positives.
Table 5.2: Area under the curve for the several feature sets and classi-
fiers for the classification normal days and exacerbation in
COPD
Features Log. regression Neural Net SVM
Set 1 45.0 (13.6) 68.7 (3.0) 74.0 (20.3)
Set 2 65.7 (14.0) 67.0 (17.6) 82.0 (21.4)
Set 3 58.9 (12.1) 59.5 (7.1) 75.0 (16.5)
All 66.5 (15.3) 82.5 (16.2) 90.0 (8.7)
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Figure 5.4: ROC curve for Feature Set 1
Figure 5.5: ROC curve for Feature Set 1
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Figure 5.6: ROC curve for the feature set after selection
5.3 parameters of pa in kora-age
The research in cooperation with the KORA-Age project and its
results, presented in this section, contribute to the answer to re-
search question RQ3 regarding the extraction of features from
accelerometer data for research in pulmonary health.
Following the stated criteria, 162 subjects were eligible for
analysis. In total 24 subjects were excluded due to insufficient
days of recordings (ankle: n=3, hip: n=2, both: n=19). All out-
come variables were checked by artificial time series as well as
by PA data from randomly chosen subjects.
Analysis of the artificial time series in table 5.3: For all tests
the start and stop times indicated that the sensors were worn
all through the day with some gaps during the day. This is ex-
pected as all time series had the length of one day, although
the 30minute test had wearing gaps during the day that aren’t
considered for the start and stop time. Non-wear periods: The
tests const10 and 1to100 produced results that indicate that sen-
sors are used all the time. The random test produced a plausi-
ble random output. The 20minutes test had an identified non-
wearing period by the last minutes of the time series and was ac-
curate within the expected results of the algorithm by Hecht. The
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30minutes test produced several non-wearing periods as it has
zero sequences longer than the threshold of 20 minutes. Average
time non-worn: Tests const10 and 1to100 output a zero, because
sensors were used all the time. The 20minutes test produced re-
sult zero because the Hecht threshold period is 20 minutes and
overlapped with the time series. The 30minutes test showed the
10 minutes that separate the 30minute pattern to the threshold of
Hecht et al. which is 20 minutes. Activity levels in Metabolic Equiv-
alent of Task (MET): The values in test const10 are all in the low
activity quartile. 1to100 is as expected. 20minutes and 30minutes
return very close results as expected. Activity levels in Quartiles:
const10 shows all results in the last quartile as it is constant. In
the Random test, because of the moving average the upper quar-
tile limit is close to 100% and the values in the test are averaged
around 100, so most time shows on the fourth quartile. The test
1to100 is correct because of applying a moving average to a step
function, quartiles are evenly distributed. The tests 20m and 30m
are either on the first or fourth quartile.
Table 5.3: Output of the features for the artificial timeseries
daysTotal 1.00 1.00 1.00 1.00 1.00
avgNonWearL 0.00 0.00 0.00 0.00 10.00
Variable Const10 Random 1to300 20min 30min
totalHWearL 24.00 23.99 24.00 23.83 15.81
totalHWearH 24.00 23.99 24.00 23.83 15.81
startWearHL 0.00 0.00 0.00 0.00 0.00
startWearML 0.00 0.00 0.00 0.00 0.00
startWearHH 23.00 23.00 23.00 23.00 23.00
startWearMH 59.00 59.00 59.00 49.00 29.00
nonWearPerCntL 0.00 10.00 0.00 1.00 46.00
nonWearPerCntH 0.00 10.00 0.00 1.00 46.00
avgNonWearH 0.00 0.00 0.00 0.00 10.00
averageActL 10.00 99.96 50.50 50.35 75.91
standardDevL 0.00 49.61 28.87 50.00 42.76
averageActH 10.00 99.96 50.50 50.35 75.91
standardDevH 0.00 49.61 28.87 50.00 42.76
max1HMovAvgH 10.00 102.62 50.50 50.00 50.00
max1HMovAvgL 10.00 102.62 50.50 50.00 50.00
HMax1hMovAvgL 0.00 20.00 0.00 0.00 0.00
MMax1hMovAvgL 44.00 4.00 46.00 34.00 14.00
HMax1hMovAvgH 0.00 20.00 0.00 0.00 0.00
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daysTotal 1.00 1.00 1.00 1.00 1.00
avgNonWearL 0.00 0.00 0.00 0.00 10.00
MMax1hMovAvgH 44.00 4.00 46.00 34.00 14.00
avgDailyMETL 1.45 1.52 1.48 1.48 1.50
avgDailyMETH 1.45 1.52 1.48 1.48 1.50
sedentaryMETL 1.00 0.32 0.76 0.50 0.24
lowMETL 0.00 0.68 0.24 0.50 0.76
mediumMETL 0.00 0.00 0.00 0.00 0.00
highMETL 0.00 0.00 0.00 0.00 0.00
sedentaryMETH 1.00 0.32 0.76 0.50 0.24
lowMETH 0.00 0.68 0.24 0.50 0.76
mediumMETH 0.00 0.00 0.00 0.00 0.00
highMETH 0.00 0.00 0.00 0.00 0.00
sedQrtActL 0.00 0.08 0.14 0.50 0.24
lowQrtActL 0.00 0.12 0.13 0.00 0.00
medQrtActL 0.00 0.19 0.14 0.00 0.00
highQrtActL 1.00 0.61 0.56 0.50 0.76
sedQrtActH 0.00 0.08 0.14 0.50 0.24
lowQrtActH 0.00 0.12 0.13 0.00 0.00
medQrtActH 0.00 0.19 0.14 0.00 0.00
highQrtActH 1.00 0.61 0.56 0.50 0.76
longPrdSedL 0.00 1.00 2.00 7.00 7.00
longPrdSedH 0.00 1.00 2.00 7.00 7.00
Table 5.5 shows the output of the parameter extraction process
for the randomly selected subjects. It shows the values produced
by my code, for each of the proposed features. For instance the
first table indicates the estimated number of days the sensors
were worn, feature named daysTotal, and since the test was per-
formed on a single day of data the result is always 1. All the
values are within expected ranges for a normal subject. Subject
K78 has a very distinct value for the features avgNonWearL and
avgNonWearH, 10 and 117 respectively, unlike all other subjects.
This most likely due to not wearing one of the sensors, for com-
fort, on the day under analysis. Several subjects show no counts
at the high levels of activity, an indication of sedentary behavior,
as indicated by the features highMETL and highMETH. During
the test day subject K96 had a continuous activity profile with
no long breaks - an unusual pattern in the overall study.
Table 5.5: Output of the features for the randomly selected subjects
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Variable K1 K9 K76 K78 K92 K96 K102 K114 K145 K186
standardDevH 30.77 41.64 28.98 23.9 35.65 111.43 37.36 39.98 27.74 41.62
MMax1hMovAvgH 33 55 16 8 4 1.47 7 28 16 21
highQrtActL 0.04 0.01 0.03 0.01 0.06 0.89 0.05 0.01 0.01 0.03
daysTotal 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
totalHWearL 10.13 13.55 12.82 5.67 14.43 9.45 12.56 15.23 14.08 11.92
totalHWearH 9.30 13.23 13.12 5.39 13.59 10 12.56 15.23 11.70 11.92
startWearHL 9 7 6 12 7 22 9 8 0 8
startWearML 5 42 52 1 19 23 3 14 0 34
startWearHH 22 22 20 19 22 59 23 23 23 20
startWearMH 11 17 44 21 11 20 53 28 58 29
nonWearPerCntL 16 10 13 10 3 23 22 0 33 0
nonWearPerCntH 20 12 10 1 9 1 26 1 19 0
avgNonWearL 11 6 5 10 9 11 6 0 18 0
avgNonWearH 11 7 5 117 9 33.89 5 0 39 0
averageActL 23.41 43.95 35.81 14.79 31.52 92.62 24.02 29.45 22.01 34.23
standardDevL 71.82 101.79 99.93 42.72 55.82 12.67 70.81 79.84 63.04 110.41
averageActH 12.64 19.95 10.16 7.28 23.35 36.26 14.82 16.13 10.78 18.55
max1HMovAvgH 112.48 242.3 83.2 24.12 59.94 27.09 78.04 120.45 53.00 128.88
max1HMovAvgL 42.84 96.15 21.4 15.62 37.33 12 39.76 61.16 21.95 45.92
HMax1hMovAvgL 10 14 15 17 10 46 11 11 1 10
MMax1hMovAvgL 30 55 12 22 7 14 2 28 16 30
HMax1hMovAvgH 10 14 11 17 10 50 11 11 11 15
avgDailyMETL 1.4 1.47 1.47 1.45 1.46 1.45 1.46 1.46 1.45 1.47
avgDailyMETH 1.4 1.45 1.45 1.44 1.46 0.86 1.45 1.45 1.44 1.45
sedentaryMETL 0.93 0.84 0.87 0.92 0.82 0.14 0.9 0.89 0.89 0.9
lowMETL 0.13 0.16 0.13 0.08 0.18 0 0.1 0.11 0.10 0.1
mediumMETL 0 0 0 0 0 0 0 0 0 0
highMETL 0 0 0 0 0 0.93 0 0 0 0
sedentaryMETH 0.91 0.88 0.95 0.98 0.91 0.07 0.9 0.92 0.95 0.91
lowMETH 0.14 0.12 0.05 0.02 0.09 0 0.1 0.08 0.04 0.09
mediumMETH 0 0 0 0 0 0 0 0 0 0
highMETH 0 0 0 0 0 0.94 0 0 0 0
sedQrtActL 0.92 0.87 0.89 0.92 0.76 0.04 0.9 0.94 0.91 0.94
lowQrtActL 0.03 0.04 0.04 0.05 0.09 0.02 0.03 0.04 0.05 0.02
medQrtActL 0.02 0.08 0.04 0.03 0.09 0 0.02 0.02 0.02 0.01
sedQrtActH 0.83 0.82 0.88 0.91 0.63 0.06 0.85 0.87 0.87 0.86
lowQrtActH 0.02 0.06 0.05 0.05 0.08 0.04 0.03 0.06 0.07 0.08
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Variable K1 K9 K76 K78 K92 K96 K102 K114 K145 K186
standardDevH 30.77 41.64 28.98 23.9 35.65 111.43 37.36 39.98 27.74 41.62
MMax1hMovAvgH 33 55 16 8 4 1.47 7 28 16 21
highQrtActL 0.04 0.01 0.03 0.01 0.06 0.89 0.05 0.01 0.01 0.03
medQrtActH 0.05 0.06 0.05 0.02 0.07 0.02 0.03 0.04 0.03 0.03
highQrtActH 0.05 0.06 0.02 0.02 0.21 566 0.09 0.04 0.01 0.03
longPrdSedL 506 265 128 340 97 239 192 419 173 306
longPrdSedH 90 263 139 306 56 0 99 216 131 256
5.4 acceptance and reliability
The results on usability and reliability of the different sensors
from the pilot and CF studies contribute to answering research
question RQ4, focusing on the feasibility of long term monitor-
ing with off the shelf sensors.
We identified several technical limitations of the sensors. The
most severe one is the short battery life on RT3 and the inability
to recharge it while in use. Furthermore and even worse all the
values stored on the sensor are lost if the battery runs empty.
This leads to a limited time window for measuring, collecting the
sensors and storing the acquired data in a permanent storage.
The data quality is very high, on average, for the GT1M, RT3
and Polar RS800 sensors, with stable measurements and few or
no missing values. The only exception was the Polar RS800 af-
ter a few hours of use in some of the subjects. The electrodes
need some moisture to provide a good electrical conductivity
with the skin. With long uninterrupted use they tend to dry out
severely and the signal quality is significantly degraded. The
wrist unit on the sensor warns the user on this situation most of
the times, and allows a solution by moistening the skin under
the electrodes.
Figure 5.7 illustrates the data collected for one of the measure-
ment period from an 86 years old subject. The data of the heart
rate sensor (Polar) is missing from 12:50 until 16:00 due to poor
electrode conductivity. Some spikes in the measured heart rate,
around 16:40 and 17:10 are also likely due to poor contact as the
activity level was very low and stable at these times.
In Table 5.7 we present the feedback from the cystic fibrosis pa-
tients we asked to participate in the study, regarding the reasons
for not accepting to take part.
5.5 summary
We presented, in this chapter, the main results of our research.
While applying classification algorithms to the data from ac-
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Table 5.7: Feedback from the patients about participation in the study
Gender Feedback
M none
M “I do not know what my girlfriend is going
to think about me wearing the sensors”
F “The sensors are too clumsy too wear at
work.”
F “Cannot use red one beneath the tight
trousers or the high shoes. The grey one is
too visible to wear”
M none
M “3 weeks is too long. I will accept 1 week.
Are the alarms in the shops going to start
because of the sensor?”
F “3 weeks is too long”
M “Going for a golf tournament for 10 days.
Cannot use them because of balance”
F “Having other complications from asthma.
Physical activity very low”
F none
M “I have bad sleep, so the night movement
info is very important”
M “21 days is very long” Extensive explanation





Figure 5.7: Example recording from the feasibility study with missing
data from heart rate sensor
celerometers we achieved 85% accuracy in distinguishing CF pa-
tients from healthy subjects, based on a small set of features
extracted from the data. With larger sets of features from the
COPD study we were able to distinguish exacerbation days from
normal days in patients, with the best algorithm support vector
machines able to achieve an area under the curve of 90%. The
features we extracted from the KORA-Age data indicate a low
activity profile of the subjects. Our results indicate that the code
we developed for the extraction of these features is formally cor-
rect.
We found that in terms of usability the long term use of sen-
sors pose challenges. We had a group of young CF patients re-
fusing to participate in the study mostly on usability concerns.
We noted that the long term monitoring of heart rate is prone to
errors and missing data, and is badly accepted by the subjects.
6
D I S C U S S I O N
In this chapter we discuss the essential aspects of the research
results. The first section discusses the usability concerns relat-
ing to research question RQ4. Section 2 deals with the results
and shortcomings of the classification in CF patients, relating
to research question RQ1 and giving insight to research ques-
tion RQ5 on the methods used. The third section is focused on
the classification of days in COPD, relating to research question
RQ2 and providing more insight to research question RQ5. The
last section is devoted to the discussion of the results of extract-
ing features for the KORA-Age study, contributing for research
question RQ3.
6.1 classification of cf patients and controls
I achieved reasonable sensitivity and specificity in distinguish-
ing Cystic Fibrosis patients from control subjects, when conduct-
ing simple PA modeling with subsequent use of a neural net-
work. My results indicate that the data collected by the leg sen-
sor is more robust for this task. I used a set of simple features
as input for the NN, inspired by the scatter plot of the data.
These results help us to answer the feasibility of studying classi-
fication tasks of Cystic Fibrosis patients (research question RQ1),
aiming at studying the classification of exacerbation episodes
and gives us information on the best methods for such tasks (re-
search question RQ5). The results are not statistically significant
due to study limitations and low acceptance of potential partici-
pants.
Many other types of features have been used and proposed for
the analysis of accelerometer data, namely large sets of hetero-
geneous features [117] and other instances based on frequency
domain [77] or time-scale analysis [81, 80]. According to the pub-
lished results existing applications focus on short-term monitor-
ing. To our knowledge this was the first use of a classification
system for data from long-term monitoring with accelerometers.
Our results with this small set of simple features indicate that
further work on more robust features may increase the accuracy
of classification.
Naturally, the clinically interesting application is not the dis-
tinction from healthy subjects but the individual characterization
of patients as well as the possibility to detect changes over time,
possibly supported by an individually trained neuronal network
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implemented in the activity monitor itself. Correspondingly, the
detection or prediction of exacerbations in CF patients remains
an issue for further studies. Future studies must consider longer
periods of recording and a larger study group to be able to cover
a significant number of exacerbations.
The small size of the study group in Cystic Fibrosis does not
allow us to draw definitive conclusions.
I present the results of the whole study with CF patients and
controls in paper P2.
6.2 classification of days in copd
The work on classification normal days and days of exacerba-
tions in COPD patients is, to my knowledge, the first attempt
to extract a set of features from accelerometer data. Although
we recruited 45 patients to the study, I was dealing with unpre-
dictable exacerbation occurrences, making it hard to capture a
significant number of episodes during a monitoring period. To
increase the number of exacerbations I would need ask the pa-
tients to wear the sensors for very long periods, raising usability
and acceptance issues.
I carried out the study in an in-clinic setting with patients un-
der daily medical supervision, thus it is hard to generalize the
results to a daily living setting. Overall the classifiers achieved
reasonable performance but I think it is not enough for medical
relevance, even if the current alternative is having no classifica-
tion method at all. Even if the SVM had a 90% AUC for the best
feature set, the other classifiers never exceeded 82%.
Overall SVM showed to be the most robust classifier for this
task. As for features, none of the basic feature sets proved ro-
bust enough for this problem. Only the combination of all the
extracted features (after a feature selection process) provided
enough information for reasonable classification power.
The difference of classification power between the 3 feature
sets I implemented hint that the relationship between the move-
ment of different body parts holds useful information for this
task. To some extent this information has previously been ex-
plored in the existing algorithms for activity identification, for
instance in user interface research. The basic features, such as
average and standard deviation, included in feature set 1 is of
little use alone.
I think that future work on the classification of exacerbations
will be needed including recruiting a larger study group, achiev-
ing higher number of exacerbation episodes, as well on explor-
ing other sets of features focusing on different aspects of the
accelerometer data.
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I present the main results and conclusions of the data collec-
tion, analysis and classification of exacerbation episodes in paper
P3 and P4
6.3 pa parameters for lung research
The experience I acquired while collecting and processing ac-
celerometer data in the scope of the KORA-Age study contributes
to global knowdlege of the best practices in accelerometry stud-
ies.
After research by the team on methods to determine total time
of wearing as well as the time spent in different PA levels, we
decided to adapt and apply the algorithm by Hecht et al. for
the estimation of wearing time and the algorithm by Freedson
et al. for estimation of PA levels. The algorithm by Hecht et al.
seemed to be most appropriate because of the use of a triaxial ac-
celerometer and similar age of the study population (66.8 years
vs 75.1years).
I developed customized Matlab scripts to calculate several PA
outcome parameters from accelerometer data. These scripts were
thoroughly tested in a two-step approach. The tests of the code
proved the scripts to be producing reliable and reasonable out-
puts, ensuring high quality of data for the cohort colaborators.
The results indicate a very sedentary activity profile, from
10 random subjects, with little or no activity recorded at the
medium and high quartiles. The extracted features provided a
good overall picture of the activity profiles of the subjects, includ-
ing total activity at leg and hip, profile of the resting/no activity
periods as well absolute and individual specific measurements
of the activity. This will give the opportunity to compare techni-
cal aspects of measurement, such as best location of the sensors,
but also associations to the health outcomes.
Our experience, results and conclusions with KORA-Age co-
hort are detailed and discussed in paper P5.
6.4 recruitment and acceptance
I found few significant reports of the difficulties and methods
used in one crucial step of all projects: the recruitment of par-
ticipants for the studies. Most studies refer in one paragraph
to monetary compensation of the participants, place where re-
cruitment occurred, but provide no references to the recruitment
method, lessons learned and feedback from it. I present the us-
ability results and problems in papers P1, P2 and P3. Paper P1
is essential focused on the usability and reliability problems of
long term sensor wearing. P2 and P3 present some insights and
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results on this question as complement to a main research ques-
tion (RQ4).
Kahan et al.[120] and Coevering et al.[121] presented a signif-
icant report of recruitment strategies for physical activity stud-
ies in adults. Kahan et al. focused on Middle Eastern-American
young adults, but only reports on non-clinical environment se-
tups. They conclude that active recruitment techniques such as
presentations at target communities were more effective than
passive techniques such as flyers. Coevering et al.explored dif-
ferent strategies to recruit and increase compliance of American
middle school students. They suggest that compensation or in-
centives are a good strategy for improving compliance, as well as
frequent personal contact with participants. Trost et al .reviewed
several methodological issues when conducting accelerometer
based studies, including compliance of participants, which is
closely related to acceptance and recruiting. Nevertheless they
don’t provide relevant information on the recruitment issue.
Other works present some discussion on recruitment, for in-
stance Jancey et al.[122] research the motivational factors for ex-
ercise in elderly people and Duncan et al.[123] focus on partici-
pation of school children who need consent from their parents to
participate. I believe that we can’t relate their studies to mine be-
cause they focus on the motivation for exercise itself or consent
from a third person.
Books [124] on recruitment for clinical trials discuss topics of
patient acceptance and strategies for good patient recruitment
and retention. Nevertheless, such literature focuses on drug trial
studies where the perceived health benefit for participants is
more immediate.
When I started to conduct studies in this topic, taking into
consideration the existing literature and reports, I aimed at de-
signing good study protocols and define clear scientific goals –
which are obviously fundamental aspects – but assumed recruit-
ment would not pose a major challenge.
From the first feasibility study with healthy volunteers it be-
came clear that some technical aspects of the sensors can become
a big drawback on the setup of a large study. Battery life and its
implications on the storage of measured values is a critical one,
not only limiting the duration of the trial but also putting the
whole data set’s collection in jeopardy. Correct preparation and
handling of the sensors by the staff is also crucial, as proven by
the high rate of unsuccessful measurement periods due to mis-
handling and preparation of the sensors. For this I produced an
extensive set of work instructions, covering all aspects of data
collection, reset and handling of the sensors. The skin irritation
from prolonged use of heart rate sensors is also critical, as the
data quality is affected and the user must be prompted to take an
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active role by moistening the electrodes. Although other kinds
of electrodes do exist, they are inappropriate for a passive, non-
interfering use of sensors.
Regarding the feedback from potential participants in the CF
study I think that young subjects are more concerned about
fashion and personal appearance. Therefore, strange-looking de-
vices are not welcome in their daily life. I identified a gender
dependence of the acceptability of such devices that has not
been widely reported. The color and positioning of the devices
were clearly a major drawback. Women showed less willingness
to wear devices citing reasons of fashion or comfort. Men, on
the other hand, used technical proficiency and social status ar-
guments as reasons to accept the disturbance of wearing these
fairly uncomfortable devices. These usability issues seem to be
confirmed by the lower compliance rate for this group as com-
pared to older patients. The RT3 sensor, possibly because of the
old-fashioned design, had slightly shorter wearing time than the
GT1M. Our observations point towards the need for inconspic-
uous devices if these should be implemented in the long-term
monitoring of patients in future. They also suggest that devices
placed at the ankle will always face acceptance problems.
Nevertheless, it took the team a significant amount of effort
and time to achieve acceptable recruitment rates and I clearly
improved the methods and techniques as experience increased.

7
C O N C L U S I O N S
RQ1 - Is it feasible to study episodes of exacerbation in Cystic Fibrosis
patients by exploring accelerometer data?
I didn’t achieve robust results regarding the study of exacerba-
tion episodes in CF. The low number of exacerbation episodes
in the study period made it statistically difficult. I explored the
capacity of the accelerometer data to distinguish the movement
patterns of patients and control subjects. Using a very simple set
of features extracted from the data I obtained results that indi-
cate good capacity of classification of a neural network.
Many other types of features have been used and proposed
for the analysis of accelerometer data [81, 80, 77, 117], focused
on short term monitoring. This is the first use of data from long-
term monitoring and analysis for classification of chronic dis-
ease. However, the small sample size of this pilot study did not
allow me draw further conclusions. Naturally, the clinically in-
teresting application is not the distinction from healthy subjects
but the individual characterization of patients as well as the pos-
sibility to detect changes over time, possibly supported by an
individually trained neural network implemented into the activ-
ity monitor.
Future studies exploring the use of PA data in exacerbations
in CF must be longer and with more subjects involved, in order
to increase the number of exacerbations recorded. In this study
I overestimated the likelihood of exacerbations during winter
time. The data in one of the patients seemed promising, although
I had missed the period prior to the exacerbation from recording.
Future studies must consider longer periods of recording and a
larger study group to be able to cover a significant number of
exacerbations.
Other authors have explored similar concepts of predicting ex-
acerbations in CF from other data sources not directly from PA,
but no definitive results are known [15]. The question remains
open to future research.
RQ2 - Can we distinguish normal days from exacerbation in COPD
patients looking at accelerometer data?
To the best of my knowledge this thesis presented the first at-
tempt to distinguish days with exacerbation episodes from nor-
mal days in COPD patients using accelerometer data. I achieved
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promising results with our approach, that indicate good poten-
tial for future improvement and clinical application. The best
results indicate an area under the curve of the classifier of 90%.
Nevertheless the number of patients and episodes is too low to
draw definitive conclusions. These results were achieved with a
significant number of features, but in a limited scope of infor-
mation extracted. I envisage that future approaches with larger
feature sets and with larger scope of information present in such
features can improve the classification quality. Only then is it fea-
sible to aim at clinical use of accelerometers in the management
of COPD patients.
I would like to emphasize that the use of PA recording for
the purpose of exacerbation prediction in patients with COPD
seems a very reasonable approach for future research, given the
unreliability of lung function recording at home and the non-
objectivity of symptoms. From clinical studies and common ex-
perience it is well known that physical capacity and activity are
associated with the clinical state, in particular exacerbations [17].
The results in this thesis indicate that not only there is such sta-
tistical association, but that we can directly distinguish events in
the life of patients based on PA data. Data from accelerometers
should be explored for not only linear changes of physical ac-
tivity before and during exacerbation, but also exploring other
dimensions of the time series, such as frequency or scale. The
ease of use and large datasets generated make them good tools
for that.
One of the limitations in our studies is the low sampling rate, a
few samples per minute, of the sensors used, as I focused on off
the shelf sensors. Currently, there is technology capable of sam-
pling rates above the Mhz during long periods of time. When
these sensors become available in a easy to use and validated
product, a greater improvement in the results can be expected.
I can also expect better results with a more robust approach to
the data processing. Instead of a simple and straightforward ap-
proach as the one presented, we propose the use of activity iden-
tification from accelerometer data as input for the classification
algorithms. The accelerometer data can be used to estimate the
type and duration of the different activities performed (walk,
running, standing....) and that information to be fed to the clas-
sification algorithms, together with other features, as input. This
approach becomes feasible with sensors capable of high sam-
pling rate.
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RQ3 - Can we extract innovative features from accelerometer data that
are useful for pulmonary research in general population?
Yes, I extracted a large set of parameters from the accelerome-
ter data according to the needs and recommendations from the
scientific staff of the KORA-Age study dealing with lung health
studies. These features will be available to all study partners and
can provide a working platform for future epidemiological stud-
ies. These features can be used in the study of the importance of
PA to the pulmonary health at the population level. By making
the results available to other researchers this study contributes
to the knowledge of the PA in the general population. It is also
an improvement on the common guidelines that focus only on
activity levels and compare them to existing guidelines [125].
The testing procedures were focused on analyzing the data ex-
tracted for correctness and expected values. We found no abnor-
mal values, neither did the cohort partners. The data is already
available for lung research and any other research topic that the
partners may find relevant.
The experience acquired in this thesis can contribute to future
work in large cohorts and studies using accelerometers to assess
PA in the population, by providing guidelines for best practices
and avoiding common mistakes and pitfalls.
RQ4 - What are the essential barriers to long term monitoring of
chronic patients and elderly people?
I identified several barriers to participation and retention of sub-
jects in our studies: the social and comfort aspects of wearing
sensors for long periods, and limitations of the sensors regard-
ing data reliability and battery limitations.
During the recruitment of subjects for our studies I received
different responses from the potential participants and signifi-
cant feedback from the participants. I had to exclude the long
term monitoring of heart rate because of the early feedback re-
garding the skin problems and low usability of the Polar heart
rate sensor. I found that recruitment and acceptance of partic-
ipation in studies that require the use of sensors for long pe-
riods measuring physical activity is under-reported. Kahan et
al.[120]and Coevering et al.[121]discuss the recruitment strate-
gies for physical activity studies in adults, but do not address
the use of sensors as a source of refusal to participate.
The younger CF patients mentioned aesthetics and social rea-
sons to refuse participation in the study. The color and size of the
sensors were mentioned. The complexity of use was not raised
as a barrier.
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According to my results, manufacturers of accelerometer de-
vices for medical applications should pay more attention to fash-
ion related issues and aim to develop devices which appeal to a
young population by choosing neutral or skin-like colors, trendy
form factors or perhaps by integrating these sensors into com-
monly used devices such as mobile phones. The success of prod-
ucts, focused on the sports market, such as Nike + ipod (Nike
corp. Beaverton, Oregon) and Fitbit (Fitbit, San Francisco, Cali-
fornia), should be taken into consideration when designing sen-
sors for medical applications. I suggest that this can raise the
acceptance of usage in such groups to a reasonable percentage,
with the consequence that long-term, quasi-continuous record-
ing becomes feasible.
The older participants of the COPD study were generally more
willing to participate, although I expected at the beginning that
the age would increase the concerns with usability. A confusing
factor is that in the COPD study we had direct medical support
on the recruitment. This might have changed the perceived ben-
efit and difficulty of participation.
In the KORA-Age study we achieved the best acceptance of
the subjects. This is in line with the experience from the other
KORA-Age researchers.
RQ5 - What is the performance of different methods applied to the
previous research questions?
In this work it was found that Neural Networks and Support
Vector machines provide the best results in classification tasks
based on accelerometer data. For the classification of CF patients
and healthy subjects I tested neural networks with a simple set
of features and achieved an accuracy of 85%. In the classifica-
tion of COPD exacerbations neural networks achieved an area
under the curve of 82.5% and the support vector machines a
area of 90%. These results indicate good classification capacity
for both methods, nevertheless one must take into consideration
the small sample size of both studies. I think that improvements
in the feature extraction phase combined with larger studies can
lead to clinical applications of the exacerbation classification in
COPD patients.
Future work
The next logical step in the effort to classify exacerbations in
COPD patients is to design a larger study, aiming to obtain data
for a statistically significant number of exacerbation episodes.
This is the essential step towards assessing the feasibility of the
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proposed approach, and to gain better insight into the medical
consequences.
Obviously the question of medical interest is not to classify
the exacerbations episodes after they occur or when they are oc-
curring, but be able to alert the patients ahead of their onset.
I think that the approach proposed in this thesis is also valid
for this scenario: the same data can contain this information. A
larger study looking at the classification of exacerbations after
they were detected, can also provide information on the feasibil-
ity of the same data providing cues for the forecast of the same
exacerbations. The data processing, namely the feature extrac-
tion step and classification, need to reflect the different task, but
essentially the steps will be the same.
As I used a simple classification method, in future studies ex-
isting knowledge must be taken into account when exploring
and implementing better features from the accelerometer data.
This can provide an improvement of the classification results.
Namely, I think that an approach based on identifying the type
of activity, such as walking or standing, and its duration can
provide better information. There are several known algorithms
that can identify to a good degree the activities, so this shouldn’t
pose a major obstacle.
Naturally researchers in KORA-Age will continue to use the
data collected, and explore the medical and epidemiological as-
sociations of PA. The continued research will provide future in-
sights into new parameters of use that can be extracted from ac-
celerometer data. It is important that such collaboration is kept
and extended.

B I B L I O G R A P H Y
[1] M. Ezzati, A. D. Lopez, A. Rodgers, S. Hoorn,
and C. Murray, “Selected major risk factors and
global and regional burden of disease,” The Lancet,
vol. 360, no. 9343, pp. 1347 – 1360, 2002. [Online].
Available: http://www.sciencedirect.com/science/article/
pii/S0140673602114036 (Cited on page 3.)
[2] W. Spirduso, “Physical dimensions of aging. Champaign:
Human Kinetics;,” 1995. (Cited on page 3.)
[3] R. P. Troiano, “A Timely Meeting: Objective Measurement
of Physical Activity,” Medicine & Science in Sports &
Exercise, vol. 37, no. Supplement, pp. S487–S489, Nov.
2005. [Online]. Available: http://dx.doi.org/10.1249/01.
mss.0000185473.32846.c3 (Cited on page 4.)
[4] S. G. Trost, K. L. McIver, and R. R. Pate, “Conducting
Accelerometer-Based Activity Assessments in Field-Based
Research,” Medicine & Science in Sports & Exercise, vol. 37,
no. Supplement, pp. S531–S543, Nov. 2005. [Online].
Available: http://dx.doi.org/10.1249/01.mss.0000185657.
86065.98 (Cited on page 4.)
[5] K. R. Westerterp, “Assessment of physical activity: a criti-
cal appraisal,” Eur J Appl Physiol, vol. 105, no. 6, pp. 823–8,
Apr 2009. (Cited on pages 4 and 17.)
[6] R. A. Pauwels and K. F. Rabe, “Burden and clinical fea-
tures of chronic obstructive pulmonary disease (copd),”
The Lancet, vol. 364, no. 9434, pp. 613 – 620, 2004. (Cited
on page 4.)
[7] S. Spencer, P. M. Calverley, P. B. Sherwood, and
P. W. Jones, “Health status deterioration in patients
with chronic obstructive pulmonary disease.” American
journal of respiratory and critical care medicine, vol. 163,
no. 1, pp. 122–128, Jan. 2001. [Online]. Available:
http://view.ncbi.nlm.nih.gov/pubmed/11208636 (Cited
on page 4.)
[8] J. Blic, M. Le Bourgeois, and D. Hubert, Mucoviscidose. Edi-
tions Scientifiques et Medicales Elsevier, 2001, vol. 5, pp.
1–14. (Cited on page 5.)
[9] M. Rosenfeld, R. Davis, S. FitzSimmons, M. Pepe, and
B. Ramsey, “Gender gap in cystic fibrosis mortality.”
75
76 bibliography
American journal of epidemiology, vol. 145, no. 9, pp.
794–803, May 1997. [Online]. Available: http://view.ncbi.
nlm.nih.gov/pubmed/9143209 (Cited on page 5.)
[10] C. Foundation. (2008) Cystic Fibrosis Foundation Patient
Registry 2008 Annual Data Report. Bethesda, Maryland.
(Cited on page 5.)
[11] H. Hebestreit, S. Kieser, S. Rudiger, T. Schenk, S. Junge,
A. Hebestreit, M. Ballmann, H. G. Posselt, and S. Kriemler,
“Physical activity is independently related to aerobic
capacity in cystic fibrosis,” Eur Respir J, vol. 28,
no. 4, pp. 734–739, Oct. 2006. [Online]. Available:
http://dx.doi.org/10.1183/09031936.06.00128605 (Cited
on pages 5 and 24.)
[12] H. Kolberg, “Cystic fibrosis and physical activity:
An introduction,” International Journal of Sports
Medicine, vol. 9, no. SUPPL. 1, pp. 2–5, 1988.
[Online]. Available: http://www.scopus.com/inward/
record.url?eid=2-s2.0-0023871585&partnerID=40&md5=
f46887c74a10747907526bdef6b304a4 (Cited on page 5.)
[13] P. A. Nixon, D. M. Orenstein, S. F. Kelsey, and
C. F. Doershuk, “The prognostic value of exercise
testing in patients with cystic fibrosis,” N Engl J Med,
vol. 327, no. 25, pp. 1785–1788, Dec. 1992. [Online].
Available: http://content.nejm.org/cgi/content/abstract/
327/25/1785 (Cited on page 5.)
[14] D. M. Orenstein, P. A. Nixon, E. A. Ross, and R. M. Kaplan,
“The quality of well-being in cystic fibrosis.” Chest, vol. 95,
no. 2, pp. 344–347, Feb. 1989. [Online]. Available: http:
//dx.doi.org/10.1378/chest.95.2.344 (Cited on page 5.)
[15] D. D. Frangolias, C. L. Holloway, S. Vedal, and P. G.
Wilcox, “Role of exercise and lung function in predicting
work status in cystic fibrosis.” American journal of
respiratory and critical care medicine, vol. 167, no. 2, pp.
150–157, Jan. 2003. [Online]. Available: http://dx.doi.org/
10.1164/rccm.2202053 (Cited on pages 5 and 69.)
[16] L. Beghin, F. Gottrand, L. Michaud, H. Vodougnon,
N. Wizla-Derambure, R. Hankard, M. O. Husson, and
D. Turck, “Energetic cost of physical activity in cystic fibro-
sis children during Pseudomonas aeruginosa pulmonary
exacerbation.” Clinical nutrition (Edinburgh, Scotland),
vol. 24, no. 1, pp. 88–96, Feb. 2005. [Online]. Avail-
able: http://dx.doi.org/10.1016/j.clnu.2004.07.020 (Cited
on pages 5 and 25.)
bibliography 77
[17] T. Troosters, D. Langer, B. Vrijsen, J. Segers, K. Wouters,
W. Janssens, R. Gosselink, M. Decramer, and L. Dupont,
“Skeletal muscle weakness, exercise tolerance and physical
activity in adults with cystic fibrosis.” The European
respiratory journal, vol. 33, no. 1, pp. 99–106, Jan. 2009.
[Online]. Available: http://dx.doi.org/10.1183/09031936.
00091607 (Cited on pages 5, 24, and 70.)
[18] C. Fournier, L. Bosquet, S. Leroy, T. Perez, R. Neviere,
and B. Wallaert, “Measurement of daily physical activity
in patients with cystic fibrosis,” Revue des maladies
respiratoires, vol. 22, no. 1 Pt 1, pp. 63–69, Feb.
2005. [Online]. Available: http://view.ncbi.nlm.nih.gov/
pubmed/15968759 (Cited on pages 5 and 24.)
[19] T. Troosters, R. Casaburi, R. Gosselink, and M. De-
cramer, “Pulmonary rehabilitation in chronic ob-
structive pulmonary disease.” American journal of
respiratory and critical care medicine, vol. 172,
no. 1, pp. 19–38, Jul. 2005. [Online]. Available:
http://dx.doi.org/10.1164/rccm.200408-1109SO (Cited on
page 5.)
[20] H. Q. Nguyen, B. Steele, and J. O. Benditt, “Use of
accelerometers to characterize physical activity patterns
with COPD exacerbations.” International journal of chronic
obstructive pulmonary disease, vol. 1, no. 4, pp. 455–460,
2006. [Online]. Available: http://view.ncbi.nlm.nih.gov/
pubmed/18044101 (Cited on pages 5 and 16.)
[21] R. Holle, M. Happich, H. Löwel, H. E. Wichmann, and
MONICA/KORA Study Group, “Kora–a research plat-
form for population based health research,” Gesundheitswe-
sen, vol. 67 Suppl 1, pp. S19–25, Aug 2005. (Cited on
pages 8, 9, and 34.)
[22] A. Peters, A. Döring, K.-H. Ladwig, C. Meisinger,
B. Linkohr, C. Autenrieth, S. E. Baumeister, J. Behr,
A. Bergner, H. Bickel, M. Bidlingmaier, A. Dias, R. T.
Emeny, B. Fischer, E. Grill, L. Gorzelniak, H. Hänsch,
S. Heidbreder, M. Heier, A. Horsch, D. Huber, R. M. Huber,
R. A. Jörres, S. Kääb, S. Karrasch, I. Kirchberger, G. Klug,
B. Kranz, B. Kuch, M. E. Lacruz, O. Lang, A. Mielck,
D. Nowak, S. Perz, A. Schneider, H. Schulz, M. Müller,
H. Seidl, R. Strobl, B. Thorand, R. Wende, W. Weidenham-
mer, A.-K. Zimmermann, H.-E. Wichmann, and R. Holle,
“[multimorbidity and successful aging: the population-
based kora-age study],” Z Gerontol Geriatr, vol. 44 Suppl
2, pp. 41–54, Dec 2011. (Cited on page 9.)
78 bibliography
[23] J. Steier and W. Petro, “Physikalische therapie bei copd -
evidence based medicine? physical therapy in copd - ev-
idence based medicine?” Pneumologie, vol. 56(6), pp. 388–
396, 2002. (Cited on page 9.)
[24] J. P. Lynch, A. Partridge, K. Law, T. Kenny, A. Kiremid-
jian, and E. Carryer, “Design of piezoresistive mems-based
accelerometer for integration with wireless sensing unit
for structural monitoring,” Journal of Aerospace Engineering,
vol. 16, pp. 108–114, 2003. (Cited on page 15.)
[25] C. C. Yang and Y. L. Hsu, “A review of accelerometry-
based wearable motion detectors for physical activity mon-
itoring,” Sensors, vol. 10, no. 8, pp. 7772–7788, 2010. (Cited
on page 15.)
[26] A. Godfrey, R. Conway, D. Meagher, and G. OLaighin, “Di-
rect measurement of human movement by accelerometry,”
Med Eng Phys, vol. 30, no. 10, pp. 1364–86, Dec 2008. (Cited
on pages 15 and 16.)
[27] P. Chien-Yu and C. F. Georgia, “Physical activity pat-
terns in youth with autism spectrum disorders,” Journal
of Autism and Developmental Disorders, vol. 36, no. 5, pp.
597–606, July 2006. (Cited on page 16.)
[28] P. A. G. A. Committee, “Physical activity guidelines advi-
sory committee report,” Department of Health and Human
Services: Washington, pp. 1–683, 2008. (Cited on pages 16
and 17.)
[29] H. K. Neilson, P. J. Robson, C. M. Friedenreich, and
I. Csizmadi, “Estimating activity energy expenditure: how
valid are physical activity questionnaires?” Am J Clin Nutr,
vol. 87, no. 2, pp. 279–91, Feb 2008. (Cited on page 17.)
[30] L. Vanhees, J. Lefevre, R. Philippaerts, M. Martens,
W. Huygens, T. Troosters, and G. Beunen, “How to assess
physical activity? how to assess physical fitness?” Eur J
Cardiovasc Prev Rehabil, vol. 12, no. 2, pp. 102–14, Apr 2005.
(Cited on page 17.)
[31] I. Zakeri, A. L. Adolph, M. R. Puyau, F. A. Vohra, and N. F.
Butte, “Application of cross-sectional time series modeling
for the prediction of energy expenditure from heart rate
and accelerometry,” J Appl Physiol, vol. 104, no. 6, pp. 1665–
73, Jun 2008. (Cited on page 18.)
[32] S. L. Wolf, C. J. Winstein, J. P. Miller, E. Taub, G. Uswatte,
D. Morris, and C. Giuliani, “Effect of constraint-induced
movement therapy on upper extremity function 3 to 9
bibliography 79
months after stroke,” JAMA, vol. 296, no. 17, pp. 2095–
2104, 2006. (Cited on page 18.)
[33] K. V. M. K. R. J. J. Bouten, C.V.; Koekkoek, “A triaxial ac-
celerometer and portable data processing unit for the as-
sessment of daily physical activity,” IEEE. Trans. Biomed.
Eng, vol. 44, pp. 136–147, 1997. (Cited on page 18.)
[34] S. Brage, N. Brage, P. W. Franks, U. Ekelund, M. Wong,
L. B. Andersen, K. Froberg, and N. J. Wareham, “Branched
equation modeling of simultaneous accelerometry and
heart rate monitoring improves estimate of directly mea-
sured physical activity energy expenditure,” J Appl Physiol,
vol. 96, no. 1, pp. 343–51, Jan 2004. (Cited on page 18.)
[35] S. Brage, N. Brage, U. Ekelund, J. Luan, P. W. Franks,
K. Froberg, and N. J. Wareham, “Effect of combined move-
ment and heart rate monitor placement on physical activ-
ity estimates during treadmill locomotion and free-living,”
Eur J Appl Physiol, vol. 96, no. 5, pp. 517–24, Mar 2006.
(Cited on page 18.)
[36] K. Corder, S. Brage, N. J. Wareham, and U. Ekelund, “Com-
parison of paee from combined and separate heart rate
and movement models in children,” Med Sci Sports Exerc,
vol. 37, no. 10, pp. 1761–7, Oct 2005. (Cited on page 18.)
[37] J. Staudenmayer, D. Pober, S. Crouter, D. Bassett, and
P. Freedson, “An artificial neural network to estimate phys-
ical activity energy expenditure and identify physical ac-
tivity type from an accelerometer,” J Appl Physiol, vol. 107,
no. 4, pp. 1300–7, Oct 2009. (Cited on page 19.)
[38] M. P. Rothney, M. Neumann, A. Béziat, and K. Y. Chen,
“An artificial neural network model of energy expenditure
using nonintegrated acceleration signals,” J Appl Physiol,
vol. 103, no. 4, pp. 1419–27, Oct 2007. (Cited on page 19.)
[39] S. de Graauw, J. de Groot, M. van Brussel, M. Streur,
and T. Takken, “Review of prediction models to
estimate activity-related energy expenditure in children
and adolescents.” International journal of pediatrics, vol.
2010, 2010. [Online]. Available: http://dx.doi.org/10.
1155/2010/489304 (Cited on page 19.)
[40] P. S. Freedson, E. Melanson, and J. Sirard, “Calibration of
the Computer Science and Applications, Inc. accelerom-
eter.” Medicine and science in sports and exercise, vol. 30,
no. 5, pp. 777–781, May 1998. [Online]. Available:
http://view.ncbi.nlm.nih.gov/pubmed/9588623 (Cited
on pages 19 and 28.)
80 bibliography
[41] D. Hendelman, K. Miller, C. Baggett, E. Debold, and
P. Freedson, “Validity of accelerometry for the assessment
of moderate intensity physical activity in the field,” Med
Sci Sports Exerc, vol. 32, no. 9 Suppl, pp. S442–9, Sep 2000.
(Cited on page 19.)
[42] A. M. Swartz, S. J. Strath, R. Bassett, David,
W. Obrien, G. A. King, and B. E. Ainsworth,
“Estimation of energy expenditure using CSA ac-
celerometers at hip and wrist sites,” Medicine &
Science in Sports & Exercise, vol. 32, no. Supplement,
pp. S450–S456, Sep. 2000. [Online]. Available: http:
//dx.doi.org/10.1097/00005768-200009001-00003 (Cited
on page 19.)
[43] U. Ekelund, M. Sjostromm, A. Yngve, E. Poortvliet,
A. Nilsson, K. Froberg, N. Wedderkopp, and K. Westerterp,
“Physical activity assessed by activity monitor and doubly
labeled water in children.” Medicine and science in
sports and exercise, vol. 33, no. 2, pp. 275–281, Feb.
2001. [Online]. Available: http://view.ncbi.nlm.nih.gov/
pubmed/11224818 (Cited on page 19.)
[44] M. R. Puyau, A. L. Adolph, F. A. Vohra, and
N. F. Butte, “Validation and calibration of physical
activity monitors in children.” Obesity research, vol. 10,
no. 3, pp. 150–157, Mar. 2002. [Online]. Available: http:
//dx.doi.org/10.1038/oby.2002.24 (Cited on page 19.)
[45] S. Trost, R. R. Pate, J. F. Sallis, P. S. Freedson, W. C.
Taylor, M. Dowda, and J. Sirard, “Age and gender
differences in objectively measured physical activity
in youth.” Medicine and science in sports and exercise,
vol. 34, no. 2, pp. 350–355, Feb. 2002. [Online]. Available:
http://view.ncbi.nlm.nih.gov/pubmed/11828247 (Cited
on page 19.)
[46] S. G. Trost, R. Way, and A. D. Okely, “Predictive Validity
of Three ActiGraph Energy Expenditure Equations for
Children,” Medicine & Science in Sports & Exercise, vol. 38,
no. 2, pp. 380–387, Feb. 2006. [Online]. Available: http:
//dx.doi.org/10.1249/01.mss.0000183848.25845.e0 (Cited
on page 19.)
[47] K. Corder, S. Brage, and U. Ekelund, “Accelerometers
and pedometers: methodology and clinical application,”
Current Opinion in Clinical Nutrition and Metabolic Care,
vol. 10, no. 5, pp. 597–603, Sep. 2007. [Online]. Avail-
able: http://dx.doi.org/10.1097/MCO.0b013e328285d883
(Cited on page 19.)
bibliography 81
[48] D. X. Sun, G. Schmidt, S. Teo-Koh, and M. Miang,
“Validation of the RT3 accelerometer for measuring
physical activity of children in simulated free-living
conditions.” Pediatric exercise science, vol. 20, no. 2, pp. 181–
197, May 2008. [Online]. Available: http://view.ncbi.nlm.
nih.gov/pubmed/18579899 (Cited on pages 19 and 29.)
[49] A. Nilsson, S. Brage, C. Riddoch, S. A. Anderssen,
L. B. Sardinha, N. Wedderkopp, L. B. Andersen, and
U. Ekelund, “Comparison of equations for predicting
energy expenditure from accelerometer counts in chil-
dren.” Scandinavian journal of medicine & science in sports,
vol. 18, no. 5, pp. 643–650, Oct. 2008. [Online]. Avail-
able: http://dx.doi.org/10.1111/j.1600-0838.2007.00694.x
(Cited on page 19.)
[50] S. E. Crouter, J. R. Churilla, J. Bassett, and R. David, “Es-
timating energy expenditure using accelerometers,” Eur J
Appl Physiol, vol. 98, no. 6, pp. 601–12, Dec 2006. (Cited on
page 19.)
[51] S. Brage, N. Wedderkopp, P. W. Franks, L. B. Andersen,
and K. Froberg, “Reexamination of validity and reliabil-
ity of the csa monitor in walking and running,” Med Sci
Sports Exerc, vol. 35, no. 8, pp. 1447–54, Aug 2003. (Cited
on page 19.)
[52] A. G. Brooks, S. M. Gunn, R. T. Withers, C. J. Gore, and J. L.
Plummer, “Predicting walking mets and energy expendi-
ture from speed or accelerometry,” Med Sci Sports Exerc,
vol. 37, no. 7, pp. 1216–23, Jul 2005. (Cited on pages 19
and 28.)
[53] D. P. Heil, “Predicting activity energy expenditure
using the Actical activity monitor.” Research quarterly
for exercise and sport, vol. 77, no. 1, pp. 64–80, Mar.
2006. [Online]. Available: http://view.ncbi.nlm.nih.gov/
pubmed/16646354 (Cited on page 19.)
[54] N. Y. J. M. Leenders, T. E. Nelson, and W. M. Sherman,
“Ability of different physical activity monitors to detect
movement during treadmill walking,” Int J Sports Med,
vol. 24, no. 1, pp. 43–50, Jan 2003. (Cited on page 19.)
[55] J. F. Nichols, E. Wellman, S. Caparosa, J. F. Sallis, K. J. Cal-
fas, and R. Rowe, “Impact of a worksite behavioral skills
intervention,” Am J Health Promot, vol. 14, no. 4, pp. 218–21,
ii, 2000. (Cited on page 19.)
[56] A. Yngve, A. Nilsson, M. Sjostrom, and U. Ekelund, “Effect
of monitor placement and of activity setting on the mti
82 bibliography
accelerometer output,” Med Sci Sports Exerc, vol. 35, no. 2,
pp. 320–6, Feb 2003. (Cited on pages 19 and 28.)
[57] N. J. Klippel and D. P. Heil, “Validation of energy
expenditure prediction algorithms in adults using the
actical electronic activity monitor,” Medicine & Science in
Sports & Exercise, vol. 35, no. Supplement 1, pp. S284+,
May 2003. [Online]. Available: http://dx.doi.org/10.1097/
00005768-200305001-01580 (Cited on page 19.)
[58] K. Lyden, S. L. Kozey, C. A. Howe, J. W. Staudenmayer,
and P. S. Freedson, “A Comprehensive Evaluation Of
Accelerometer Energy Expenditure And Met Prediction
Equations,” Medicine & Science in Sports & Exercise,
vol. 41, no. Supplement 1, pp. 156+, May 2009. [Online].
Available: http://dx.doi.org/10.1249/01.MSS.0000355033.
75817.38 (Cited on page 19.)
[59] M. P. Rothney, E. V. Schaefer, M. M. Neumann,
L. Choi, and K. Y. Chen, “Validity of Physical
Activity Intensity Predictions by ActiGraph, Actical,
and RT3 Accelerometers,” Obesity, vol. 16, no. 8,
pp. 1946–1952, May 2008. [Online]. Available: http:
//dx.doi.org/10.1038/oby.2008.279 (Cited on page 19.)
[60] A. L. Evans, G. Duncan, and W. Gilchrist, “Recording ac-
celerations in body movements,” Med Biol Eng Comput,
vol. 29, no. 1, pp. 102–4, Jan 1991. (Cited on page 20.)
[61] N. Wang, E. Ambikairajah, S. J. Redmond, B. G.
Celler, and N. Lovell, “Classification of walking patterns
on inclined surfaces from accelerometry data,” in
2009 16th International Conference on Digital Signal
Processing. IEEE, Jul. 2009, pp. 1–4. [Online]. Available:
http://dx.doi.org/10.1109/ICDSP.2009.5201202 (Cited on
page 20.)
[62] B. Auvinet, D. Chaleil, and E. Barrey, “Accelerometric gait
analysis for use in hospital outpatients,” Rev Rhum Engl
Ed, vol. 66, no. 7-9, pp. 389–97, 1999. (Cited on page 20.)
[63] R. Moe-Nilssen and J. L. Helbostad, “Estimation of gait
cycle characteristics by trunk accelerometry,” J Biomech,
vol. 37, no. 1, pp. 121–6, Jan 2004. (Cited on page 20.)
[64] R. Moe-Nilssen, J. L. Helbostad, J. B. Talcott, and F. E. Toen-
nessen, “Balance and gait in children with dyslexia,” Exp
Brain Res, vol. 150, no. 2, pp. 237–44, May 2003. (Cited on
page 20.)
bibliography 83
[65] M. Nyan, F. Tay, K. Seah, and Y. Sitoh, “Classification of
gait patterns in the time-frequency domain,” Journal of
Biomechanics, vol. 39, no. 14, pp. 2647–2656, 2006. [Online].
Available: http://www.sciencedirect.com/science/article/
B6T82-4H877R3-2/2/d3ae79128f428969ff171507230d6403
(Cited on page 20.)
[66] M. N. Nyan, F. E. H. Tay, M. Manimaran, and K. W.
Seah, “Garment-based detection of falls and activities of
daily living using 3-axis MEMS accelerometer,” Journal
of Physics: Conference Series, vol. 34, pp. 1059–1067, 2006.
[Online]. Available: http://iopscience.iop.org/1742-6596/
34/1/175?ejredirect=migration (Cited on page 20.)
[67] H. B. Menz, S. R. Lord, and R. C. Fitzpatrick, “Age-related
differences in walking stability,” Age Ageing, vol. 32, no. 2,
pp. 137–42, Mar 2003. (Cited on page 20.)
[68] ——, “Acceleration patterns of the head and pelvis when
walking are associated with risk of falling in community-
dwelling older people,” J Gerontol A Biol Sci Med Sci,
vol. 58, no. 5, pp. M446–52, May 2003. (Cited on page 20.)
[69] N. Sakurai and M. Sasaki, “An activity monitor study on
the sleep-wake rhythm of healthy aged people residing in
their homes,” Psychiatry Clin Neurosci, vol. 52, no. 2, pp.
253–5, Apr 1998. (Cited on page 21.)
[70] S. D. Youngstedt, D. F. Kripke, J. A. Elliott, and M. R.
Klauber, “Circadian abnormalities in older adults,” J Pineal
Res, vol. 31, no. 3, pp. 264–72, Oct 2001. (Cited on page 21.)
[71] C. A. Glod, M. H. Teicher, A. Polcari, C. E. McGreenery,
and Y. Ito, “Circadian rest-activity disturbances in children
with seasonal affective disorder,” J Am Acad Child Adolesc
Psychiatry, vol. 36, no. 2, pp. 188–95, Feb 1997. (Cited on
page 21.)
[72] G. Jean-Louis, D. F. Kripke, R. J. Cole, J. D.
Assmus, and R. D. Langer, “Sleep detection
with an accelerometer actigraph: comparisons with
polysomnography.” Physiology & behavior, vol. 72,
no. 1-2, pp. 21–28, Jan. 2001. [Online]. Available:
http://view.ncbi.nlm.nih.gov/pubmed/11239977 (Cited
on page 21.)
[73] E. Sazonov, N. Sazonova, S. Schuckers, and M. Neuman,
“Activity-based sleep-wake identification in infants.”
Physiological measurement, vol. 25, no. 5, pp. 1291–1304,
Oct. 2004. [Online]. Available: http://view.ncbi.nlm.nih.
gov/pubmed/15535193 (Cited on page 21.)
84 bibliography
[74] A. Sadeh and C. Acebo, “The role of actigraphy in sleep
medicine,” Sleep Medicine Reviews, vol. 6, no. 2, pp. 113–124,
2002. (Cited on page 21.)
[75] A. Godfrey, R. Conway, M. Leonard, D. Meagher, and
G. Olaighin, “Motion analysis in delirium: A discrete
approach in determining physical activity for the purpose
of delirium motoric subtyping,” Medical Engineering &
Physics, vol. 32, no. 2, pp. 101–110, Mar. 2010. [Online].
Available: http://www.sciencedirect.com/science/article/
B6T9K-4XRBH63-1/2/c3dc5ab5f591e50cf133c5eef3a19841
(Cited on page 21.)
[76] A. Godfrey, R. Conway, M. Leonard, D. Meagher, and
G. M. Olaighin, “A continuous wavelet transform and
classification method for delirium motoric subtyping,”
IEEE Transactions on Neural Systems and Rehabilitation
Engineering: A Publication of the IEEE Engineering in
Medicine and Biology Society, vol. 17, no. 3, pp. 298–307,
Jun. 2009. [Online]. Available: http://www.ncbi.nlm.nih.
gov/pubmed/19497833 (Cited on page 21.)
[77] T. M. E. Nijsen, R. M. Aarts, P. J. M. Cluitmans, and P. A. M.
Griep, “Time-frequency analysis of accelerometry data for
detection of myoclonic seizures,” IEEE Trans Inf Technol
Biomed, vol. 14, no. 5, pp. 1197–203, Sep 2010. (Cited on
pages 21, 63, and 69.)
[78] G. Rigas, A. T. Tzallas, D. G. Tsalikakis, S. Konitsiotis,
and D. I. Fotiadis, “Real-time quantification of resting
tremor in the Parkinson’s disease.” Conference proceedings :
... Annual International Conference of the IEEE Engineering in
Medicine and Biology Society. IEEE Engineering in Medicine
and Biology Society. Conference, vol. 2009, pp. 1306–1309,
Sep. 2009. [Online]. Available: http://dx.doi.org/10.1109/
IEMBS.2009.5332580 (Cited on page 22.)
[79] D. M. Sherrill, R. Hughes, S. S. Salles, T. Lie-Nemeth,
M. Akay, D. G. Standaert, and P. Bonato, “Advanced
Analysis of Wearable Sensor Data to Adjust Medication
Intake in Patients with Parkinson?s Disease,” in Conference
Proceedings. 2nd International IEEE EMBS Conference on
Neural Engineering, 2005. IEEE, 2005, pp. 202–205.
[Online]. Available: http://dx.doi.org/10.1109/CNE.2005.
1419591 (Cited on page 22.)
[80] M. Akay, M. Sekine, T. Tamura, Y. Higashi, and T. Fuji-
moto, “Fractal dynamics of body motion in post-stroke
hemiplegic patients during walking,” J Neural Eng, vol. 1,
no. 2, pp. 111–6, Jun 2004. (Cited on pages 22, 63, and 69.)
bibliography 85
[81] M. Sekine, M. Akay, T. Tamura, Y. Higashi, and T. Fuji-
moto, “Fractal dynamics of body motion in patients with
parkinson’s disease,” J Neural Eng, vol. 1, no. 1, pp. 8–15,
Mar 2004. (Cited on pages 22, 63, and 69.)
[82] M. Sekine, T. Tamura, M. Akay, T. Fujimoto, T. Togawa,
and Y. Fukui, “Discrimination of walking patterns using
wavelet-based fractal analysis,” IEEE Trans Neural Syst Re-
habil Eng, vol. 10, no. 3, pp. 188–96, Sep 2002. (Cited on
page 22.)
[83] B. Knorr, R. Hughes, D. Sherrill, J. Stein, M. Akay, and
P. Bonato, “Quantitative Measures of Functional Upper
Limb Movement in Persons after Stroke,” in Conference
Proceedings. 2nd International IEEE EMBS Conference on
Neural Engineering, 2005. IEEE, 2005, pp. 252–255.
[Online]. Available: http://dx.doi.org/10.1109/CNE.2005.
1419604 (Cited on page 22.)
[84] S. Patel, K. Lorincz, R. Hughes, N. Huggins, J. Growdon,
D. Standaert, M. Akay, J. Dy, M. Welsh, and P. Bonato,
“Monitoring motor fluctuations in patients with Parkin-
son’s disease using wearable sensors,” Trans. Info. Tech.
Biomed., vol. 13, no. 6, pp. 864–873, Nov. 2009. [Online].
Available: http://dx.doi.org/10.1109/TITB.2009.2033471
(Cited on page 22.)
[85] M. J. Gibson, “The prevention of falls in later life. a report
of the kellogg international work group on the prevention
of falls by the elderly,” Dan. Med. Bull, vol. 34-4, pp. 1–24.,
1987. (Cited on page 22.)
[86] K. O. Berg, B. E. Maki, J. I. Williams, P. Holliday, and
S. L. Wood-Dauphinee, “Clinical and laboratory measures
of postural balance in an elderly population,” Arch. Phys.
Med. Rehabil, vol. 73, pp. 1073–1080, 1992. (Cited on
page 22.)
[87] S. R. Lord, H. B. Menz, and A. Tiedemann, “A physio-
logical profile approach to fall risk assessment and pre-
vention,” Phys. Ther, vol. 83, pp. 237–252, 2003. (Cited on
page 22.)
[88] K. Doughty, R. Lewis, and A. McIntosh, “The design of
a practical and reliable fall detector for community and
institutional telecare,” J Telemed Telecare, vol. 6 Suppl 1, pp.
S150–4, 2000. (Cited on page 22.)
[89] K. C. K. B. D. Williams, G.; Doughty, “A smart fall and ac-
tivity monitor for telecare applications,” in In Proceedings
86 bibliography
of the 20th Annual International Conference of the IEEE Engi-
neering in Medicine and Biology Society, 1998, pp. 1151–1154.
(Cited on page 22.)
[90] D. M. Karantonis, M. R. Narayanan, M. Mathie, N. H.
Lovell, and B. G. Celler, “Implementation of a real-time
human movement classifier using a triaxial accelerometer
for ambulatory monitoring,” IEEE Trans Inf Technol Biomed,
vol. 10, no. 1, pp. 156–67, Jan 2006. (Cited on pages 23
and 43.)
[91] C. Yang and Y. Hsu, “Development of a wearable motion
detector for telemonitoring and real-time identification of
physical activity,” Telemed J E Health, vol. 15, no. 1, pp. 62–
72, Jan 2009. (Cited on page 23.)
[92] M. M. Budge, B. G. Celler, S. R. Lord, N. H. Lovell, and
M. R. Narayanan, “Fall management: Detection and pre-
vention using a waist mounted triaxial accelerometer,” in
Proceedings of IEEE Engineering Medical Biology Society, 2007,
pp. 4037–4040. (Cited on page 23.)
[93] A. K. Bourke, P. van de Ven, M. Gamble, R. O’Connor,
K. Murphy, E. Bogan, E. McQuade, P. Finucane,
G. Olaighin, and J. Nelson, “Evaluation of waist-mounted
tri-axial accelerometer based fall-detection algorithms dur-
ing scripted and continuous unscripted activities,” J
Biomech, vol. 43, no. 15, pp. 3051–7, Nov 2010. (Cited on
page 23.)
[94] U. Lindemann, A. Hock, M. Stuber, W. Keck, and C. Becker,
“Evaluation of a fall detector based on accelerometers: a
pilot study,” Med Biol Eng Comput, vol. 43, no. 5, pp. 548–
51, Sep 2005. (Cited on page 24.)
[95] M. Marschollek, A. Rehwald, K. H. Wolf, M. Gietzelt,
G. Nemitz, H. Meyer Zu Schwabedissen, and R. Haux,
“Sensor-based fall risk assessment - an expert ’to go’,”
Methods Inf Med, vol. 50, no. 2, Jan 2011. (Cited on page 24.)
[96] M. Marschollek, A. Rehwald, K. H. Wolf, M. Gietzelt,
G. Nemitz, H. Meyer, and R. Haux, “Assessing elderly
persons’ fall risk using spectral analysis on accelerometric
data–a clinical evaluation study,” Conf Proc IEEE Eng Med
Biol Soc, vol. 2008, pp. 3682–5, 2008. (Cited on page 24.)
[97] J. B. Dingwell and J. P. Cusumano, “Nonlinear time se-
ries analysis of normal and pathological human walking,”
Chaos, vol. 10, no. 4, pp. 848–863, Dec 2000. (Cited on
page 24.)
bibliography 87
[98] G. D. Wells, D. L. Wilkes, J. Schneiderman-Walker,
M. Elmi, E. Tullis, L. C. Lands, F. Ratjen, and A. L. Coates,
“Reliability and validity of the habitual activity estimation
scale (HAES) in patients with cystic fibrosis.” Pediatric
pulmonology, vol. 43, no. 4, pp. 345–353, Apr. 2008. [Online].
Available: http://dx.doi.org/10.1002/ppul.20737 (Cited
on page 25.)
[99] J. Marin, S. Carrizo, C. Casanova, P. Martinez-Camblor,
S. JB, A. Agusti, and B. Celli, “Prediction of risk of copd
exacerbations by the bode index,” Respir Med, vol. 103, pp.
373–8, 2009. (Cited on page 25.)
[100] M. Miniati, S. Monti, M. Bottai, F. Cocci, E. Fornai, and
V. Lubrano, “Prognostic value of c-reactive protein in
chronic obstructive pulmonary disease,” Intern Emerg Med,
vol. 6, no. 423-30, 2011. (Cited on page 25.)
[101] P. Almagro, B. Barreiro, A. Ochoa de Echaguen, S. Quin-
tana, M. Rodríguez Carballeira, J. Heredia, and J. Ga-
rau, “Risk factors for hospital readmission in patients
with chronic obstructive pulmonary disease,” Respiration,
vol. 73, pp. 311–7, 2006. (Cited on page 25.)
[102] K. Ong, A. Earnest, and S. Lu, “A multidimensional grad-
ing system (bode index) as predictor of hospitalization for
copd,” Chest, vol. 128, pp. 3810–6, 2005. (Cited on page 25.)
[103] M. Jensen, S. Cichosz, B. Dinesen, and O. Hejlesen, “Mov-
ing prediction of exacerbation in chronic obstructive pul-
monary disease for patients in telecare,” J Telemed Telecare,
vol. 18, pp. 99–103, 2012. (Cited on page 25.)
[104] F. Garcia-Rio, B. Rojo, R. Casitas, V. Lores, R. Madero,
D. Romero, R. Galera, and C. Villasante, “Prognostic value
of the objective measurement of daily physical activity
in patients with copd,” Chest, vol. 142, pp. 338–46, 2012.
(Cited on page 25.)
[105] B. Waschki, M. Spruit, H. Watz, , C. Smith, W. Man, R. Tal-
Singer, L. Edwards, P. Calverley, H. Magnussen, M. Polkey,
and E. Wouters, “Physical activity monitoring in copd:
compliance and associations with clinical characteristics in
a multicenter study,” Respir Med, vol. 106, 2012. (Cited on
page 25.)
[106] R. M. Boon, M. J. Hamlin, G. D. Steel, and J. J.
Ross, “Validation of the New Zealand Physical Activity
Questionnaire (NZPAQ-LF) and the International Physical
Activity Questionnaire (IPAQ-LF) with accelerometry,”
88 bibliography
British Journal of Sports Medicine, Nov. 2008. [Online]. Avail-
able: http://dx.doi.org/10.1136/bjsm.2008.052167 (Cited
on page 28.)
[107] S. I. de Vries, I. Bakker, M. Hopman-Rock, R. A. Hirasing,
and W. van Mechelen, “Clinimetric review of motion sen-
sors in children and adolescents,” J Clin Epidemiol, vol. 59,
no. 7, pp. 670–80, Jul 2006. (Cited on page 28.)
[108] S. Zhang, M. H. Ang, W. Xiao, and C. K. Tham,
“Detection of activities for daily life surveillance: Eating
and drinking,” in HealthCom 2008 - 10th International
Conference on e-health Networking, Applications and Services.
IEEE, Jul. 2008, pp. 171–176. [Online]. Available: http:
//dx.doi.org/10.1109/HEALTH.2008.4600131
[109] P. Bonato, D. M. Sherrill, D. G. Standaert, S. S.
Salles, and M. Akay, “Data mining techniques to
detect motor fluctuations in Parkinson’s disease,” in
The 26th Annual International Conference of the IEEE
Engineering in Medicine and Biology Society, vol. 2.
IEEE, 2004, pp. 4766–4769. [Online]. Available: http:
//dx.doi.org/10.1109/IEMBS.2004.1404319
[110] W. Dargie and M. K. Denko, “Analysis of Error-Agnostic
Time- and Frequency-Domain Features Extracted From
Measurements of 3-D Accelerometer Sensors,” IEEE
Systems Journal, vol. 4, no. 1, pp. 26–33, Mar. 2010. [Online].
Available: http://dx.doi.org/10.1109/JSYST.2009.2039735
[111] Z. He and L. Jin, “Activity recognition from ac-
celeration data based on discrete consine trans-
form and SVM,” in 2009 IEEE International Con-
ference on Systems, Man and Cybernetics. IEEE,
Oct. 2009, pp. 5041–5044. [Online]. Available:
http://dx.doi.org/10.1109/ICSMC.2009.5346042 (Cited
on page 43.)
[112] R. Ibrahim, E. Ambikairajah, B. G. Celler, and N. H.
Lovell, “Time-Frequency Based Features for Classification
of Walking Patterns,” in 2007 15th International Conference
on Digital Signal Processing. IEEE, Jul. 2007, pp.
187–190. [Online]. Available: http://dx.doi.org/10.1109/
ICDSP.2007.4288550
[113] S. J. Preece, J. Y. Goulermas, L. P. J. Ken-
ney, and D. Howard, “A Comparison of Fea-
ture Extraction Methods for the Classification
of Dynamic Activities From Accelerometer Data,”
IEEE Transactions on Biomedical Engineering, vol. 56,
bibliography 89
no. 3, pp. 871–879, Mar. 2009. [Online]. Available:
http://dx.doi.org/10.1109/TBME.2008.2006190
[114] A. M. Khan, Y. K. Lee, and T. S. Kim, “Accelerometer
signal-based human activity recognition using augmented
autoregressive model coefficients and artificial neural
nets,” in 2008 30th Annual International Conference of
the IEEE Engineering in Medicine and Biology Society.
IEEE, Aug. 2008, pp. 5172–5175. [Online]. Available:
http://dx.doi.org/10.1109/IEMBS.2008.4650379 (Cited on
page 43.)
[115] N. C. Krishnan and S. Panchanathan, “Analysis of
low resolution accelerometer data for continuous human
activity recognition,” in 2008 IEEE International Conference
on Acoustics, Speech and Signal Processing. IEEE, Mar. 2008,
pp. 3337–3340. [Online]. Available: http://dx.doi.org/10.
1109/ICASSP.2008.4518365 (Cited on page 43.)
[116] N. C. Krishnan, G. N. Pradhan, and S. Panchanathan, “Rec-
ognizing short duration hand movements from accelerom-
eter data,” in 2009 IEEE International Conference on Multi-
media and Expo. IEEE, Jun. 2009, pp. 1700–1703. [Online].
Available: http://dx.doi.org/10.1109/ICME.2009.5202848
(Cited on page 43.)
[117] J. Lester, T. Choudhury, and G. Borriello, “A Practical
Approach to Recognizing Physical Activities,” in Pervasive
Computing, ser. Lecture Notes in Computer Science,
K. Fishkin, B. Schiele, P. Nixon, and A. Quigley,
Eds. Berlin, Heidelberg: Springer Berlin / Heidelberg,
2006, vol. 3968, ch. 1, pp. 1–16. [Online]. Available:
http://dx.doi.org/10.1007/11748625_1 (Cited on pages 43,
63, and 69.)
[118] J. Parkka, M. Ermes, P. Korpipaa, J. Mantyjarvi, J. Peltola,
and I. Korhonen, “Activity Classification Using Realistic
Data From Wearable Sensors,” IEEE Transactions on
Information Technology in Biomedicine, vol. 10, no. 1, pp.
119–128, Jan. 2006. [Online]. Available: http://dx.doi.org/
10.1109/TITB.2005.856863 (Cited on page 43.)
[119] A. Hecht, S. Ma, J. Porszasz, and R. Casaburi, “Method-
ology for using long-term accelerometry monitoring
to describe daily activity patterns in COPD.” COPD,
vol. 6, no. 2, pp. 121–129, Apr. 2009. [Online]. Available:
http://dx.doi.org/10.1080/15412550902755044 (Cited on
page 43.)
[120] D. Kahan and A. Al-Tamimi, “Strategies for recruiting mid-
dle eastern-american young adults for physical activity re-
search: a case of snowballs and salaam,” J Immigr Minor
Health, vol. 11, no. 5, pp. 380–90, Oct 2009. (Cited on
pages 66 and 71.)
[121] P. Van Coevering, L. Harnack, K. Schmitz, J. E.
Fulton, D. A. Galuska, and S. Gao, “Feasibility of
Using Accelerometers to Measure Physical Activity in
Young Adolescents,” Medicine & Science in Sports &
Exercise, vol. 37, no. 5, pp. 867–871, May 2005. [Online].
Available: http://dx.doi.org/10.1249/01.MSS.0000162694.
66799.FE (Cited on pages 66 and 71.)
[122] J. Jancey, P. Howat, A. Lee, A. Clarke, T. Shilton, J. Fisher,
and H. Iredell, “Effective recruitment and retention of
older adults in physical activity research: PALS study.”
American journal of health behavior, vol. 30, no. 6, pp.
626–635, 2006. [Online]. Available: http://dx.doi.org/10.
5555/ajhb.2006.30.6.626 (Cited on page 66.)
[123] S. C. Duncan, L. A. Strycker, T. E. Duncan, and
N. R. Chaumeton, “Telephone Recruitment of a Random
Stratified Youth Sample for a Physical Activity Study.”
Journal of sport & exercise psychology, vol. 18, no. 3, pp.
353–368, Aug. 2004. [Online]. Available: http://dx.doi.
org/10.1016/j.jaging.2004.03.001 (Cited on page 66.)
[124] L. P. Diana, A Guide to Patient Recruitment and Retention,
1st ed. CenterWatch a division of Jobson Medical
Information, Apr. 2004. [Online]. Available: http://www.
worldcat.org/isbn/193062445X (Cited on page 66.)
[125] B. DM, S.-S. C, S. V, G. AL, L. N, L. R, and et al, “Us-
ing pedometers to increase physical activity and improve
health: a systematic review,” JAMA, vol. 298, no. 19, pp.
2296–2304, 2007. (Cited on page 71.)
90
Part II
I N C L U D E D P U B L I C AT I O N S

PA P E R 1
Dias, A. ; Fisterer, B.; Lamla, G.; Kuhn, K. A.; Hartvigsen, G.;
Horsch, A.. Measuring Physical Activity with Sensors: A Quali-
tative Study. Studies in Health Technology and Informatics 2009
;Volume 150. p. 475-479
93
 
PA P E R 2
Dias, A.; Gorzelniak, L.; Jorres, R.; Fischer, R.; Hartvigsen, G.;
Horsch,A.. Assessing Physical Activity in the daily life of cys-
tic fibrosis patients. Journal of Pervasive Computing. Volume 8,
Issue 6, December 2012, Pages 837–844
99
 
PA P E R 3
Gorzelniak, L.; Dias, A.; Schultz,K.; Wittmann, M.; Karrasch, S.;
Jorres, R.; Horsch,A.. Comparison of recording positions of phys-
ical activity in severe COPD. Journal Of Chronic Obstructive Pul-
monary Disease; Volume 9, Issue 5. Dias, A.; Gorzelniak, L.; Dor-
ing, A.; Hartvigsen, G.; Horsch, A.. Extracting Gait Parameters
from Raw Data Accelerometers. Studies in Health Technology
and Informatics 2011; Volume 169.
109
 
PA P E R 4
Dias, A.; Gorzelniak, L.; Schultz,K.; Wittmann, M.; Rudnik, J.;Jorres,
R.; Horsch,A.. Classification of exacerbation episodes in Chronic
Obstructive Pulmonary Disease patients. Accepted to Methods
of information in Medicine Journal
121
 
PA P E R 5
Ortlieb, S.; Gorzelniak, L.; Dias,A.; Schulz, H.; Horsch,A. Recom-
mendations for Collecting and Processing Accelerometry Data




A D D I T I O N A L P U B L I C AT I O N S

A D D I T I O N A L PA P E R 1
Dias, A.; Gorzelniak, L.; Doring, A.; Hartvigsen, G.; Horsch, A..
Extracting Gait Parameters from Raw Data Accelerometers. Stud-




A D D I T I O N A L PA P E R 2
Gorzelniak, L.; Dias, A.; Soyer, H.; Knoll, A.; Horsch, A..
Using a Robotic Arm to Assess the Variability of Motion Sensors.




A D D I T I O N A L PA P E R 3
Chen, C.; Dias, A.; Knoll, A.; Horsch, A.. A Prototype of a
Wireless Body Sensor Network for Healthcare Monitoring. Med-
ical informatics in Europe 2011; 2011-08-27 - 2011-09-01
161
 
A D D I T I O N A L PA P E R 4
Skrovseth, S.; Dias, A.; Gorzelniak, L.; Godtiebsen, F; Horsch,
A.. Scale-space methods for live processing of sensor data. Med-
ical informatics in Europe 2012; 08/2012
165
 
A D D I T I O N A L PA P E R 5
Gorzelniak L, Dias A, Bakhirev A, Knoll A, Horsch A. Does the
Low Power Mode of the Actigraph GT3X+ Accelerometer Influ-
ence the Device Output in Sleep Research in Healthy Subjects?
Stud Health Technol Inform. 2013;192:1172.
171
 
A D D I T I O N A L PA P E R 6
Dias A, Gorzelniak L, Rudnik J, Stojanovic D, Horsch A. Detect-
ing Periodic Limb Movements with Off-the-Shelf Accelerome-




A D D I T I O N A L PA P E R 7
Peters A, Döring A, Ladwig KH, Meisinger C, Linkohr B, Aut-
enrieth C, Baumeister SE, Behr J, Bergner A, Bickel H, Bidling-
maier M, Dias A, Emeny RT, Fischer B, Grill E, Gorzelniak L,
Hänsch H, Heidbreder S, Heier M, Horsch A, Huber D, Huber
RM, Jörres RA, Kääb S, Karrasch S, Kirchberger I, Klug G, Kranz
B, Kuch B, Lacruz ME, Lang O, Mielck A, Nowak D, Perz S,
Schneider A, Schulz H, Müller M, Seidl H, Strobl R, Thorand B,
Wende R, Weidenhammer W, Zimmermann AK, Wichmann HE,
Holle R. [Multimorbidity and successful aging: the population-
based KORA-Age study]. Zeitschrift für Gerontologie und Geri-
atrie. 12/2011; 44 Suppl 2:41-54.
179
 
